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ABSTRACT  
Epithelial-to-mesenchymal transition (EMT) is a process strongly implicated in cancer 
progression and dissemination. EMT and its reversion (mesenchymal-to-epithelial 
transition, MET) confer cell plasticity, allowing cell dispersion during development and 
cancer dissemination. Cancer invading cells display EMT-related features such as 
mesenchymal phenotype and/or detachment and movement towards the stroma, 
expression of vimentin (M marker), and loss of functional E-cadherin (E marker). 
Conversely, when cancer cells successfully establish metastasis at secondary sites, 
they re-acquire E markers while maintaining aggressive tumour features. The tumour 
extracellular matrix (ECM), which undergoes drastic alterations in 
composition/organization during cancer progression, has been shown to play a critical 
role in this process, namely by promoting, inhibiting, or reverting EMT. Yet, underlying 
mechanisms are still poorly understood, largely due to the lack of adequate dynamic 
models to study cell-matrix crosstalk.  
The aim of this work was to develop a new 3D in vitro model to dissect the effect of 
matrix stiffness on EMT. To set up this model, a near-normal mammary epithelial cell 
line (EpH4) was combined with a bioengineered 3D matrix of alginate functionalized 
with cell-adhesive RGD peptides. 
In the first part of the thesis, a method for dynamically switch matrix mechanical 
properties in situ was established. Using CaCl2 or SrCl2 as external crosslinking agents, 
at optimized concentrations and incubation times, the original stiffness of acellular or 
cell-laden hydrogels (3D culture) could be significantly increased. This way, the 
hydrogel’s storage moduli (G’) could be changed, ranging from that of normal 
mammary tissue (around 200 Pa) to that of malignant mammary tissues (around 4000 
Pa).  The inverse process, i.e. hydrogel softening, was promoted using sodium citrate 
as chelating agent, and cycles of hydrogels stiffening followed by softening or vice-
versa were also settled. It was demonstrated that incubation of hydrogel-entrapped 
cells in stiffening and softening agents did not significantly impair their metabolic 
activity. 
In the second part of the thesis, the behaviour of EpH4 cells cultured under 3D 
conditions in control hydrogels was evaluated. 3D culture of EpH4 cells within soft 
RGD-alginate matrices recapitulated epithelial morphogenesis. Single EpH4 cells were 
able to proliferate forming spheroids by clonal-growth, which maturated into 
organotypic mammary accini, presenting typical features as growth arrest, lumenization 
and apicobasal polarization. The maintenance of mRNA expression levels of typical E 
markers (CDH1, Ocln), with no up-regulation in expression of M markers (CDH2) and 
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EMT inducers (Zeb2), demonstrated that 3D culture within soft RGD-alginate matrices 
did not induce EMT per se. 
Finally, in the last part of the thesis, the effect of in situ matrix stiffening on 3D cultured 
EpH4 cells was investigated. Cell-laden RGD-alginate hydrogels were stiffened with 
SrCl2, to increase their storage modulus from ca. 250 Pa to ca. 4300 Pa. Stiffening was 
promoted immediately after entrapment (at day 1) or only after spheroids formation (at 
day 10). In the later case, no significant differences were observed between control 
and stiffened samples. Yet, when matrices were stiffened at the onset of the 3D 
culture, some differences were observed, namely in terms of cell proliferation and 
spheroids formation/size, which were decreased in stiffened matrices. Some 
phenotypic differences were also detected. At protein level, there was an apparent 
slight decrease of E-cadherin expression/function and a slight increase in vimentin 
expression. At mRNA level, cells in stiffened matrices had slight increased expression 
of CDH1 and CDH2 but decreased expression of Ocln and Mgat3 (E-associated 
marker). Expression of Zeb2 and Id2 (negative regulator of TGFβ1–induced EMT) 
remained unchanged. Taken together, these results demonstrate that matrix stiffing 
effectively affected the overall behaviour of 3D-cultured EpH4 cells, and may eventually 
suggest a partial transition to a more M-like state. No differences in MMP2 and MMP9 
expression between control and stiffened matrices were detected in both experimental 
set-ups. 
Although the experiments performed in this final part of the thesis are still very 
preliminary, and no consistent conclusions on stiffness-driven EMT occurrence can be 
taken at this stage, our results demonstrate the versatility of the proposed 3D model. In 
the future, this in vitro platform is expected to provide a valuable tool to improve current 
knowledge on the role of ECM properties on EMT/MET, and may help in the 
identification of putative targets for more effective anti-cancer therapies. 
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RESUMO 
Durante a transição epitélio-mesenquimal (EMT), as células epiteliais adquirem 
características mesenquimais, como o aumento da expressão de vimentina e a perda 
de caderina-E funcional. Adicionalmente, a adesão entre células e com a matriz 
extracelular é enfraquecida, o que leva as células a destacarem-se da membrana 
basal e a movimentarem-se em direcção ao estroma, aumentando a sua capacidade 
de invasão. Este processo de EMT está envolvido na progressão e disseminação 
tumoral, sendo que as células tumorais epiteliais também adquirem um fenótipo 
mesenquimal, podendo invadir o tecido e formar metástases. Quando as metástases 
se estabelecem em nichos secundários, o processo inverso – transição mesenquimal 
para epitelial (MET) ocorre e as células readquirem marcadores epiteliais, como a 
expressão de caderina-E, mantendo outras características tumorais profundamente 
agressivas. A matriz extracelular (ECM) tumoral sofre grandes alterações na sua 
composição e organização durante a progressão tumoral. Foi descrito que a ECM tem 
um papel crítico neste processo, nomeadamente por promover, inibir ou reverter a 
EMT. No entanto, os mecanismos pelos quais esta influência ocorre ainda não são 
conhecidos, devido, principalmente, à falta de modelos dinâmicos adequados para 
estudar as interacções entre a matriz e as células.  
O principal objectivo deste trabalho foi desenvolver um modelo 3D in vitro para 
caracterizar o efeito das propriedades mecânicas da ECM, designadamente, o efeito 
do aumento da rigidez da matriz in situ em EMT. Para tal, uma linha celular epitelial 
mamária (EpH4) foi combinada com uma matriz 3D de alginato funcionalizado com 
péptidos que promovem a adesão celular (RGD).   
Em primeiro lugar, foi estabelecido um método in situ para alterar dinamicamente as 
propriedades mecânicas da matriz. Com CaCl2 ou SrCl2, como agentes de crosslinking 
externo, a rigidez dos hidrogéis acelulares e celulares (3D) foi aumentada, desde 
níveis semelhantes aos do tecido mamário normal (~200 Pa) até a níveis de rigidez 
dos tecidos mamários malignos (~4000 Pa). O processo inverso, isto é, a diminuição 
da rigidez do hidrogel, foi promovido com citrato de sódio que actua como um agente 
quelante. Foram ainda estabelecidos dois ciclos de aumento e diminuição da rigidez 
ou vice-versa. Foi também demonstrado que a incubação de hidrogéis celulares 
nestes agentes não altera significativamente a actividade metabólica celular.    
Na segunda parte da tese, foi avaliado o comportamento das células EpH4 em 3D. As 
células EpH4 numa cultura 3D de alginato-RGD são capazes de manter a 
morfogénese epitelial: proliferam e formam esferóides que maturam em estruturas 
mamárias típicas denominadas de acinares. Estas estruturas evidenciaram uma fase 
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de plateau no crescimento celular, lumenização e polarização apicobasal - 
características típicas encontradas in vivo. A manutenção dos níveis de mRNA de 
marcadores E (CDH1 e Ocln), a reduzida expressão de marcadores M (CDH2) e de 
indutores de EMT (Zeb2), demonstraram que a matriz de alginato-RGD por si só não 
induz EMT nas células EpH4.  
Finalmente, na terceira parte da tese, foi observado o efeito do aumento da rigidez da 
matriz in situ. A matriz com células EpH4 foi enrijecida com SrCl2 e foi possível 
aumentar a rigidez desde ~250 Pa até ~4300 Pa. O acréscimo da rigidez da matriz 
ocorreu imediatamente a seguir ao aprisionamento celular na matriz ou só ao dia 10, 
após a formação dos esferóides. No último caso, não foram detectadas diferenças 
significativas entre as amostras controlo e as enrijecidas. No entanto, matrizes 
enrijecidas ao dia 1 tinham a formação e o tamanho dos esferóides reduzidos, menor 
proliferação celular, decréscimo na expressão de caderina-E e ligeiro aumento na 
expressão de vimentina (ao nível da proteína). Ao nível do mRNA, células em matrizes 
enrijecidas tinham expressão aumentada de CDH1 e CDH2 e expressão diminuída de 
Ocln e Mgat3 (marcador associado ao fenótipo E). A expressão de Zeb2 e Id2 
(regulador negativo da indução de EMT por TGF1) permaneceu igual. Resumindo, 
estes resultados demonstram que o aumento da rigidez da matriz afecta o 
comportamento das células EpH4 em 3D, sugerindo uma possível transição parcial 
para um fenótipo mais mesenquimal. Não foram detectadas diferenças na secreção de 
MMP2 e MMP9 entre amostras controlo e enrijecidas, em ambas as experiências. 
Apesar das experiências efectuadas na parte final da tese ainda serem preliminares e 
de não haver conclusões consistentes sobre o efeito da rigidez em EMT, os nossos 
resultados demonstram a versatilidade do modelo 3D proposto. No futuro, espera-se 
que esta plataforma 3D sirva para melhorar o conhecimento do papel das 
propriedades da ECM em EMT/MET, e para identificar alvos para terapias anti-
tumorais mais eficazes.  
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1. Introduction 
1.1. Epithelial-to-mesenchymal transition 
 
Epithelial-to-mesenchymal transition (EMT) plays a central role in embryonic 
development, wound healing and in cancer. For this reason, EMT is divided in different 
classes – EMT type 1 for embryonic morphogenesis and development, type 2 for 
inflammatory response during wound healing, tissue regeneration and organ fibrosis, 
and type 3 for pathophysiological circumstances [1]. The third type of EMT is being 
highly implicated in cancer progression [2-4]. During EMT, epithelial (E) cells 
progressively lose polarity and cell-cell contacts acquiring a mesenchymal (M) 
phenotype with increased migratory and invasive potential [4, 5] (Figure 1). EMT 
confers plasticity to cells, contributing to cell dispersion during development and cancer 
dissemination [2, 3]. In epithelial cancers, invading cells display EMT-like features such 
as a mesenchymal phenotype associated with expression of vimentin (M marker), and 
loss of epithelial E-cadherin expression, and/or detachment and movement towards the 
stroma [5, 6]. These cells may undergo the reverse process, mesenchymal to epithelial 
transition (MET), in order to grow and colonize secondary sites, forming metastasis [7]. 
During MET, cells regain epithelial features, such as increase of E-cadherin expression 
and proliferative capacity, while mesenchymal markers and transcription factors 
associated with EMT, namely Twist1, are downregulated [8].  
 
 
 
Figure 1 – Epithelial-to-mesenchymal transition (EMT) process. Epithelial cells lose cell-cell 
contacts and detach from the basement membrane, while acquiring mesenchymal 
characteristics, such as rounder aspect and capacity to invade the tissue to form metastasis 
(adapted from [9]).   
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Furthermore, due to EMT importance in cancer dissemination, this transition is 
acquiring a leading role in epithelial cancer studies, as genes and proteins involved in 
this process are being identified. Moreover, pharmaceutical compounds are being 
synthesized to target EMT in cancer patients [10]. Nevertheless, the clinical role of this 
transition is still unclear, since the majority of the studies performed on this subject 
were in traditional 2D models that are reductionist and offer limit insight into more 
physiologic behaviours, lacking the much needed proximity to animal models [11]. 
The molecular modifications inherent to the EMT program have been associated to key 
signaling pathways that may be responsible for the implementation of the cellular 
response to extracellular signals arising from the cell microenvironment. TGF1 
signaling pathway is one of the best studied mechanisms of EMT induction [12, 13] and 
its activity is detected in cancer cells invasion [14, 15]. In physiological conditions, 
TGF1 is an essential cytokine that plays an important role in development, 
differentiation and homeostasis of several tissues. Moreover, it acts as a suppressor of 
uncontrolled proliferation and transformation [12, 13]. However, this cytokine has a 
double action, since its deregulation can confer an oncogenic behavior, namely in the 
activation of EMT in tumor cells. To initiate the TGFsignaling pathway, TGF1 ligands 
bind to their receptors - TGF receptor type I and II (TGFRI and TGFRII) and the 
formation of Smad transcription factors occurs (Figure 2). These transcription factors 
will migrate to the cells’ nucleus and assist Snail and Twist families of transcription 
factors [16, 17]. Besides Smad, other downstream signaling cascades will be activated 
upon TGF1 binding to its receptor, namely Rho-like GTPases, PI3K/Akt, NFkB and 
MAPK. All these molecules will lead to the repression of genes involved in cell polarity 
and adhesion, specifically RhoA and E-cadherin [18, 19]. MAPK activity can be 
associated with an enhanced EMT and TGF1-induced MAPK activity has a 
proliferative and anti-apoptotic effect on mesenchymal cells [20]. The proliferative 
action of MAPK signaling and vimentin expression, synergistically, leads to the 
secretion of matrix metalloproteinases (MMPs) and the reorganization of the actin 
cytoskeleton [21]. The cytoskeleton reorganization leads to the formation of membrane 
protrusions, such as filopodia, lamellipodia and invadopodia. While the first one is 
composed by parallel actin filaments, the other two are a branched network of actin. 
More specifically, invadopodia is able to degrade de ECM through MMPs secretion, 
namely MMP1, MMP7 and MMP9 [22]. The formation of these protrusions is also 
regulated by TGF1  signaling, since it activates small GTPases, such as Rho, Rac 
and Cdc42 that enhance both filopodia and lamellipodia arrangement [23]. In the 
TGF1 pathway was also observed an upregulation in N-cadherin expression, which 
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augments adhesion between mesenchymal cells [24]. Besides the alterations in the 
expression of transcription factors, microRNA expression is also modified, namely the 
miR200 family that repress the translation of Zeb1 and Zeb2 mRNAs, which are 
downregulated in this scenario [25].   
 
 
Figure 2 - Activation of TGF pathway by the connection with cellular membrane TGF 
receptors - TGFRI and TGFRII [26]. 
 
In addition to TGF1, other signaling pathways are closely involved in the activation of 
EMT. (Figure 3) Hypoxia-inducible factor (HIF) is one of those examples, since it can 
activate EMT transcription factors, such as Notch and -catenin [27, 28]. HIF1-, in 
particular, can induce the expression of Twist and Snail in epithelial cells and ovarian 
carcinoma cells [29]. Wnt signalling can also be correlated with this process, since it 
can inactivate glycogen synthase kinase GSK-3, that inhibits the activation of Snail 
and LEF-1, thus inducing EMT and cell migration via decrease of E-cadherin and 
increase of mesenchymal markers [30-32]. The NFkB pathway can also be seen as an 
EMT regulator that will induce the transcription of Snail in carcinoma cell lines and 
mesothelial fibrosis [33].  
Although there are different EMT inductors, the modification in the transcription 
program seems to result in identical outcomes. Namely, the loss of E-cadherin is 
always included in that alteration. In fact, the loss of E-cadherin is associated with the 
distinct types of EMT and has been proposed as an indicator of tumor progression and 
poor prognosis both in human and murine tumors [34]. For instance, it was 
demonstrated that the change from noninvasive to invasive pancreatic cancer in a 
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transgenic mouse model can be correlated with the loss of E-cadherin expression [35]. 
Also, it was observed that the formation of lymphogenous metastasis from human lung 
carcinoma was associated with reduced E-cadherin expression [36].  
 
 
Figure 3 - Signaling pathways involved in the activation of EMT program [26]. 
  
The E-cadherin gene – CDH1, can bear mutations that will lead to the formation of a 
non-functional protein or even the absence of protein production [37] that has been 
related with tumor infiltration in breast cancer patients [38]. Epigenetic modifications in 
this gene, such as hypermethylation of the 5’ CpG islands in the promotor region, leads 
to E-cadherin silencing. This effect has been observed in invasive breast ductal 
carcinoma [39], esophageal squamous cells carcinoma [40] and gastric cancer [41]. 
Indeed, in gastric cancers the hypermethylation of CDH1 was found to be correlated 
with cancer aggressiveness and metastasis [42]. Snail, Slug and ZEB1/2 can bind 
directly to the E-box repressive elements in the promoter of CDH1, inhibiting its 
transcription [43]. Snail-induced EMT could enhanced metastasis formation in both 
human and mouse malignant melanoma [36]. Post-transcriptional modification of E-
cadherin can also occur, normally through phosphorylation or glycosylation [44, 45]. 
The loss of E-cadherin is associated with an increase of N-cadherin [46], which is a 
mesenchymal marker. 
 
1.1.1. Role of matrix mechanical properties in EMT 
 
Cancer progression (initiation, growth, invasion and metastasis) occurs through direct 
contact and/or via paracrine signaling between malignant cells and the surrounding 
tumor stromal cells. The tumor microenvironment is comprised by biochemical and 
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biomemechanical cues, as well as of a variety of cell types, such as fibroblasts, 
immune cells, vascular endothelial cells, pericytes and bone-marrow-derived cells, 
embedded in the ECM [47]. Therefore, EMT may be regulated not only by TGF1 but 
also by mechanical forces of the ECM. As demonstrated by Leight and colleagues, 
matrix rigidity regulates a switch between TG1-induced apoptosis and EMT [48]. To 
assess this, normal murine mammary gland cells (NMuMG) were cultured on 
polyacrylamide (PA) hydrogels with varying rigidity (0.4 to 60 kPa) and treated with 
TGF1 (0.1 to 1 ng/ml) [48]. They observed that the culture on different stiffness levels 
led to morphological differences, since in rigid substrates (E>14 kPa) cells were 
cuboidal, while in compliant matrices (E<1 kPa) they were rounded and formed 
spherical clusters. Treatment with TGF1 in rigid matrices led to elongated cell 
morphology and scattering of cells, both characteristic features of EMT. These results 
were further confirmed by delocalization of E-cadherin and upregulation of 
mesenchymal markers, such as N-cadherin, -SMA and Snail. Noteworthy, this TGF1 
action was higher in substrates from 1 to 8 kPa, which is similar to the stiffness of an 
excised tumor tissue (~4 kPa [49]). On softer gels, TGF1 induced apoptosis. Overall, 
these results demonstrated that matrix rigidity can regulate the cellular response to 
TGF1 In another study, using alveolar epithelial cells (RLE-6TN) cultured on PA 
hydrogels (from 2 to 32 kPa) with fibronectin conjugated with different recombinant 
variants of the RGD sequence, Markowski et al. also concluded that TGF1 (up to 0.1 
ng/mL) induced EMT only on stiff substrates (32 kPa) [50]. In fact, cells in 2 kPa 
hydrogels maintained an epithelial phenotype with prominent E-cadherin and low -
SMA staining. However, at 32 kPa, E-cadherin levels decreased while -SMA 
increased. Cytoskeleton rearrangements and stress fiber formation, which are markers 
of a transition to a mesenchymal phenotype, were significantly increased in cells 
cultured in stiffer hydrogels [50]. In the work of Gill and colleagues they used a 
metastable cell line (344SQ) with KRas and p53 mutations cultured within 
poly(ethylene glycol) (PEG) matrices (from 21 to 55 kPa) modified with bioactive 
peptides [51]. They observed that independent of matrix composition, exposure to 
TGF1 (5ng/mL) induced a loss of epithelia morphologic features, shift in expression of 
EMT marker genes (decrease of epithelial markers, such as CDH1), an increase in 
mesenchymal ones (CDH2, Vim e Zeb1) and decrease in miR-200 levels. Noteworthy, 
the matrix stiffness range analyzed in this study was higher than the range evaluated in 
previous studies. This could explain why the authors observed EMT induction in all 
PEG formulations. 
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Recently, Wei et al. developed a collagen-coated PA hydrogel with rigidity ranging from 
150 Pa to 5700 Pa in a 3D matrigel overlay culture system, with MCF10A and 
EpH4Ras cells [52]. They demonstrated that increasing matrix stiffness in the tumor 
microenvironment directly activates EMT, tumour invasion and metastasis through 
EMT-inducing transcription factor TWIST1. At lower elastic modulus, both cell types 
developed polarized ductal acini surrounded by intact basement membrane; however, 
in stiffer matrices, a partial EMT phenotype was encountered with destabilized 
basement membrane. A silencing of TWIST1 was performed in both cells, resulting in 
the prevention of an invasive phenotype at 5700 Pa, which was maintained even in the 
presence of TGF1 (5ng/mL). In the model of TWIST1 knockdown, mRNA levels of 
Snai2, Zeb1 and Zeb2 were reduced, leading to the conclusion that TWIST1 has a key 
role in the EMT gene response. Moreover, it was observed that TWIST1 has a nuclear 
localization in stiffer matrices, while in softer ones, this molecule is cytoplasmic and 
binds to G3BP2. High matrix stiffness promotes nuclear translocation of TWIST1 by 
releasing TWIST1 from its cytoplasmic binding partner G3BP2. Loss of G3BP2 and 
rising of matrix stiffness synergistically resulted in destabilization of basement 
membrane, downregulation of E-cadherin and higher expression of vimentin. In this 
work, TWIST1 was found to be a mechanomediator that enhances EMT at higher 
rigidity of the matrix.  
In fact, the ECM mechanical properties do play a crucial role on EMT induction and in 
the extent of the transition, leading to invasiveness and poor prognosis. Despite that 
the studies here presented used different materials to mimic the ECM and distinct 
ranges of stiffness, it seems clear that high matrix stiffness promote an EMT 
phenotype. Nevertheless, as this view of ECM’s mechanical role on cancer progression 
is very recent, more studies need to be performed to address this question. 
 
1.1.2. In vitro platforms to study EMT: 2D vs 3D systems 
 
2D systems have been widely used in cancer research due to their easy manipulation, 
reproducibility and the existence of a wide range of biochemical analysis readily 
adaptable to this type of platform. However, 2D analysis lack essential features present 
in physiological and pathological natural microenvironments. For example, one of the 
limitations of 2D cell culture is that cells form a monolayer of polarized cells with only 
one side of their surface area attached to the substrate and the remaining surface in 
contact with culture medium. This type of morphology can greatly limit tissue-specific 
functions of the cellular type under study [53]. Thus, traditional 2D fail to recapitulate 
key architectural features of the tumor microenvironment. 
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Differences observed between 2D and 3D cell culture models of EMT have been 
described in a few studies. For example, Maschler et al. found that EpH4 cells 
(transformed with oncogenic Ha-Ras), when stimulated with TGF1 (8ng/mL) to induce 
EMT, were able to secrete tenascin-C, which is an ECM protein known to be 
overexpressed in breast cancer. However, this phenomenon only occurred in 3D 
collagen cell culture, since cells cultured in 2D had no significant differences in 
tenascin-C levels [54]. In another study, Loessner et al. compared the interactions that 
occur between cells and the ECM in 2D vs 3D culture using two human cancer cell 
lines, namely epithelial ovarian cancer and serous adenocarcinoma cell lines. In 3D, 
the cells had higher proliferation rate comparing to 2D, which was dependent on cell-
integrin connection and on the ability to remodel the matrix [55]. Using a 3D substrate 
of chitosan-hyaluronan to promote tumor spheroid formation, Huang and colleagues 
studied EMT markers in non-small cell lung cancer cells (NSCLC) and compared to 
these cells cultured in 2D. The EMT markers, such as N-cadherin, vimentin, CD44, 
among others, were increased in 3D culture. Also, cells in 3D had increased invasion 
behavior, seen by the higher expression of matrix metalloproteinases, namely MMP2 
and MMP9, and presented higher multidrug resistance [56]. 
Another study on EMT with A431 (human squamous cell carcinoma) showed significant 
differences between 2D and 3D cell culture [57]. Here, 3D culture was performed with a 
radial flow type bioreactor that contained a high pore matrix of hydroxyapatite beads. 
First, the authors assessed the expression of common transcription repressors of E-
cadherin gene after the treatment with TGF1 (1ng/mL) in both 2D and 3D. Slug, 
Goosecoid and LEF1 were up-regulated in the 3D culture, as well as HEY1 gene, 
which is a target of Notch and HMGA2 that is a regulator of TGF1/Smad signaling. All 
these factors seemed to be decreasing the levels of E-cadherin, in a 3D-dependent 
manner. Besides E-cadherin expression, both mRNA and protein levels of -catenin 
were higher in 3D culture and the mesenchymal markers, such as vimentin and 
fibronectin were also increased in 3D culture. In fact, these mesenchymal markers 
could not be detected in 2D cell culture. A431 cells in 3D seemed to be losing their 
epithelial polarity when stimulated with 1ng/mL of TGF1, which was proved by the 
downregulation of tight junctional proteins, namely occludin, claudin and ZO-1. Integrin 
subunits, seen by both mRNA and protein levels, were also upregulated in 3D cell 
culture, namely integrin α5 and integrin αv, both known as fibronectin receptor and 
tenascin receptor, only for the last one. Interestingly, the authors also performed similar 
studies in nude mice xenotransplanted with A431 tumor tissues. The results were 
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identical to the ones found in 3D culture, which again highlights the importance of 3D 
cell culture and its ability to better mimic the in vivo environment.  
The paradigm shift from 2D to 3D culture is underway and progressing rapidly, being 
currently recognized that adding the 3rd dimension to a cell’s environment creates 
significant differences in cellular characteristics and function [58]. M Bissel’s team 
elegantly demonstrated the relevance of using 3D systems to investigate cancer 
mechanisms, by creating a prototypical model of the mammary gland acinus, where 
TGF1-induced EMT occurred [59]. 3D models where cells are completely surrounded 
by a supportive 3D matrix, i.e. hydrogel-based entrapment systems, are the most 
relevant systems for modulating cell-matrix interaction. In this type of systems, a 
crosstalk between chemical, physical and mechanical signaling will occur, modulating 
cellular responses (Figure 4). 
 
 
Figure 4 – 3D cell culture recapitulates the in vivo microenvironment. In 3D, cells are 
entrapped, surrounded by the ECM, allowing for the inter-connection between chemical, 
physical and mechanical signaling (adapted from [60]). 
 
1.2. Hydrogels as attractive ECM mimics 
 
Hydrogels are one of the most used materials to mimic ECM, mainly because they 
have similar structural, viscoelastic and diffusive transport properties, as well as high 
biocompatibility [61, 62]. Hydrogels are mainly composed of water that fills in between 
network crosslinks and the high amount of water in its composition is responsible for 
their high permeability. Physiologically in the ECM, diffusive transport is maintained by 
the pores that exist in between cells. To replicate this property, hydrogels can be 
performed with controlled crosslinking density [62]. 
Hydrogels can be produced from both natural and synthetic sources and their 
applications have been consistently increased, going from regenerative medicine, to 
drug delivery systems and cancer research. 
Hydrogels based on ECM derived protein gels such as collagen or Matrigel are 
commonly used to produce such 3D systems, but generally present high batch-to-batch 
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variability, intrinsic bioactivity and poorly tunable biochemical/biomechanical properties 
[63]. More recently, biomaterial-based platforms traditionally associated with tissue 
engineering approaches have been translated into cancer research creating improved 
models to study tumor biology [51, 63-65]. In this context, other types of systems have 
also been explored, namely polysaccharide-based hydrogels such as chitosan and 
alginate, and synthetic materials, like polylactic acid (PLA), polyglycolic acid (PGA), 
polylactic-co-glycolic acid (PLGA) and polyethylene glycol (PEG), among others. 
Polysaccharide-based and synthetic materials present some advantages over protein-
based hydrogels, such as higher batch-to-batch uniformity and more stable physical 
and chemical composition that can be tuned. However, synthetic hydrogels do not 
present intrinsic bioactivity, being unable to promote specific cell-matrix interactions. 
Nevertheless, hybrid hydrogels incorporating bioactive moieties can be prepared. For 
example, cell adhesive peptides, like the well known Arginine-Glycine-Aspartic acid 
(RGD), can be added to otherwise inert substrate to promote cell-matrix adhesion. 
Many other components can be added, such as proteins (for instance, growth factors) 
and also peptides sensible to matrix-proteases (MMPs) for promoting cell-driven 
remodeling processes [53]. A summary of different advantages and disadvantages of 
natural vs synthetic hydrogels is described in Table 1. 
 
Table 1 - Classes of materials used in 3D cell culture – natural (protein or polysaccharide-based) 
and synthetic. Advantages and disadvantages of the use of different materials are present in this table 
(adapted from [63]). 
 
Naturallly derived matrices Synthetic matrices 
Examples for 3D 
culture 
Collagen and Matrigel (protein-based), 
Alginate and Chitosan (polysaccharide-
based) 
Permit 3D culture in physiological 
conditions with high viability 
 
PA (toxic to 3D culture), PLA, PLG and 
PLGA (require processing steps) and 
PEG (compatible with 3D culture) 
Bioactivity 
Baseline bioactivity with ample ligands 
for cell adhesion and signaling; difficult 
to isolate specific bioactive factor for 
experimental study 
Requires passive protein absorption 
(PLA, PLG and PLGA) or extra 
engineering (PEG); greater control over 
bioactivity with less experimental 
confounding 
 
Mechanical 
properties 
Tunable via additional crosslinking; 
generally alters ligand density; limited to 
low-range elasticities 
Tunable with minimal/no bioactivity 
change; broad range of physiological 
elasticities 
 
Matrix 
degradation 
Cell-mediated matrix remodeling; difficult 
to control 
Predictable degradation of synthetic 
material; requires modification for cell-
mediated degradation 
Growth factor 
contamination 
Difficult to completely remove (protein-
based) None with synthetics 
PA, polyacrylamide; PLA, poly(lactic acid); PLG, poly(lactic-co-glycolic acid); PEG, poly(ethylene glycol). 
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1.2.1 Alginate hydrogels as substrates for 3D cell culture 
 
Alginate is a natural polymer extracted from brown algae. It is an unbranched 
polyssacharide composed by 1,4-linked β-D-mannuronic acid (M) and α-L-guluronic 
acid (G) residues covalently linked that vary in composition and sequence (Figure 5) 
[66]. They can be arranged in different types of sequences, namely MM-blocks, GG-
blocks and MG-blocks [67]. Alginate is found in the algae intracellular matrix as a 
mixed salt of various cations found in sea water such as Mg2+, Ca2+, Sr2+, Ba2+, and 
Na+; however it is mainly present as a Ca2+-crosslinked gel [66]. 
 
Figure 5 - Alginate structure and residues β-D-mannuronic acid (M) and α-L-guluronic 
acid (G) [68]. 
 
Alginate is able to form hydrogels under mild conditions and at physiological 
temperature and pH [69]. Another advantage of alginate hydrogels is that their 
mechanical properties can be easily tuned, so that it is possible to mimic different 
tissue stiffness levels. To achieve different stiffness values, the molecular weight, 
concentration or the degree of crosslinking can be altered or chemical modifications 
can be performed [70]. The compression modulus of alginate hydrogels can range from 
1 to 1000 kPa and the shear modulus from 0.02 to 40 kPa [71]. The major 
disadvantages of alginate are the low biodegradation rate and the lack of patterns for 
cell recognition. However, both can be overcome by chemical and biochemical 
modifications [72-78].  
Alginate has high affinity to a variety of divalent cations, such as Ca2+, Sr2+ and Ba2+, 
which crosslink the hydrogel network, a mechanism known as ionic crosslinking, due to 
their affinity to GG blocks [67]. The crosslink with cations mainly occurs between 
negatively-charged carboxylic moieties of adjacent alginate chains [79] (Figure 6). This 
affinity decreases in the order Pb2+ > Cu2+ > Cd2+ > Ba2+ > Sr2+ > Ca2+ > Co2+, Ni2+, Zn2+ 
>Mn2+ [80, 81]. 
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Figure 6 - Alginate ionic crosslinking performed by calcium ions (Ca2+) [69]. 
 
To form hydrogels, calcium ions are the most commonly used. Gelation can occur 
under external and internal conditions (in situ). The first one uses soluble salts such as 
calcium chloride (CaCl2), but this process, although it happens almost instantly, can 
lead to different crosslinking densities and concentration gradients across the hydrogel 
[82, 83]. Internal gelation with low solubility divalent cation salts, like calcium carbonate 
(CaCO3) or calcium sulfate (CaSO4), aims to diminish the gelation rate so that the 
process can be more easily controlled, leading to formation of homogenous gels [82]. 
Even though Ca2+ is an essential ion for cells, several studies used this ion for alginate 
crosslinking in tissue engineering constructs for different cell types; and all of them 
reached the conclusion that Ca2+ is well endured by cells that are in contact with 
crosslinking and uncrosslinking activities in alginate [84-88]. However, due to the 
intrinsic role that calcium ions play in cell-cell and cell-matrix interactions [89, 90] 
alternative crosslinking agents should be explored as possible alternatives. For 
instance, Ba2+ is also being widely used [91-95] and Ba2+-alginate gels are stronger 
than Ca2+-alginate ones [96]. However, it has been reported that barium may inhibit the 
K+ channels, so Ba2+ concentration should be kept to a minimum [97]. Strontium ions 
appear as a more interesting alternative, as they are considered to be non-toxic and 
form more stable hydrogels than calcium crosslinked alginate [97]. 
Morch et al. performed a study to characterize different properties of alginate gels with 
calcium, barium or strontium [97]. High-G Ca2+-alginate beads were larger than beads 
of high-M alginate and, when in the presence of barium or strontium, it was observed 
an initial size increase. The swelling of high-G alginate beads with barium and 
strontium was reduced.  For high-M alginate, no reduction on swelling was observed 
after exchanging Ca2+ with Sr2+ or Ba2+. The hydrogels’ elastic modulus was 
determined in alginate gel cylinders by small deformation compression.  High-G 
alginate gels were stronger than the high-M alginate for all the ionic crosslinkers tested, 
which is concordant with other studies [79]. For high-G alginate, even very low 
concentrations of strontium or barium increased the gel strength dramatically. 
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Strontium could increase the gel strength, even more than with calcium at the same 
concentration; however, to a lesser extent than barium [97]. 
In ionic alginate hydrogels, increasing the concentration of crosslink ions and/or the 
time of crosslinking may reinforce the crosslinking degree. On the other hand, the 
process can be reverted since crosslinking ions may be displaced by chelators (such 
as phosphate and citrate) and non-gelling cations (such as sodium and magnesium 
ions [97]), which can lead to swelling, increased pore size and ultimately gel 
destabilization and disintegration [98, 99]. These two properties allow the mechanical 
aspect of alginate-based hydrogels to be tuned ‘on demand’, as it is possible to submit 
the hydrogels to crosslinking/uncrosslinking cycles For example, Gillette et al [100] 
developed a dynamically switchable two-component collagen-alginate 3D matrix, 
where collagen acted as structural element, and alginate could be submitted to 
crosslinking/uncrosslinking cycles. Using CaCl2 as a crosslinker and sodium citrate 
(calcium chelator) as an uncrosslinking agent, the authors were able to change 
hydrogel mechanical properties in situ. Cells entrapped within these hydrogels were 
unable to spread or migrate when the matrix was in the uncrosslinked state, but not in 
the crosslinked state. In the former case, when uncrosslinked matrices were re-
crosslinked, cells remained spread but were unable to move. 
 
1.3. Aim of the thesis: developing upgraded 3D in vitro models of EMT 
 
To explore the phenotypic and transcriptional switching of cells during EMT, the 
Expression Regulation in Cancer group at IPATIMUP established an in vitro 2D model 
of TGF1-induced EMT and its reversion [45, 101]. TGF1 supply to the near-normal E 
cell line EpH4 efficiently generated M-like cells, and its removal resulted in the re-
acquisition of an epithelial-like phenotype. The later cellular state, which was named 
reversed epithelia (RE cells), is characterized by the co-existence of several and 
heterogeneous cellular populations with regard to the expression of E-cadherin (E 
marker) or fibronectin (M marker) [101]. In that 2D model, it was also demonstrated that 
RE cells, generated through MET, together with heterogeneity display increased self-
renewal potential and in vivo tumourigenesis ability [101]. RE cells, unlike E and M, 
possibly reproduce tumor heterogeneity often described in primary and metastatic 
clinical samples [102, 103]. Still, as already discussed, traditional 2D models are 
reductionist and may offer limited insight into more physiologic behaviors, as they fail to 
recapitulate key architectural features of the tumor microenvironment. 
Therefore, in a recent work in collaboration with INEB, the established 2D model 
evolved towards a new 3D in vitro model [104], by combining the inducible epithelial 
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cell line (EpH4) with a bioengineered ECM-like matrix with tunable properties, to 
explore the inter-conversion between E and M states during EMT/MET. The selected 
3D matrix, composed of an optimized soft alginate hydrogel functionalized with cell 
adhesive RGD peptides [73, 77], supported epithelial morphogenesis and allowed 
TGF1-induced generation of cells with mesenchymal-like and intermediate 
phenotypes, providing a useful tool to unravel cellular alterations associated with 
EMT/MET [104]. 
The main aim of this thesis was to further up-grade this 3D model, by optimizing a 
method for dynamically switching matrix viscoelastic properties, in situ, which will allow 
an improved understanding of the impact of the ECM biomechanics in EMT. This type 
of studies is expected to improve current knowledge on cancer progression and 
dissemination processes, and may pave the way for the identification of putative 
targets for more effective anti-cancer therapies. 
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2. Materials and Methods 
2.1. Synthesis and characterization of RGD-alginate 
 
Ultrapure sodium alginate (PRONOVA UP LVG, Novamatrix, FMC Biopolymers) with a 
molecular weight of 150 kDa and a high content of guluronic acid (~70%) was covalent 
grafted with the cell-adhesion peptide (glycine)4-arginine-glycine-aspartic acid-serine-
proline (hereafter abbreviated as RGD) using aqueous carbodiimide chemistry as 
previously described [105]. Briefly, alginate solutions (1 wt.%) in MES buffer (0.1 M 
MES, 0.3 M NaCl, pH 6.5) were prepared and stirred overnight (ON) at room 
temperature (RT). N-Hydroxy-sulfosuccinimide (Sulfo-NHS, Pierce) and 1-ethyl-
(dimethylaminopropyl)-carbodiimide (EDC, Sigma, 27.4 mg per g of alginate) were 
sequentially added at a molar ratio of 1:2, followed by 100 mg of RGD peptide 
(Genscript) per g of alginate. After stirring for 20 h at RT, the reaction was quenched 
with hydroxylamine (Sigma) and the solution was dialyzed against deionized water for 
3 days (MWCO 3500). After purification with charcoal, RGD-alginate was lyophilized 
and stored at -20ºC until further use. The reaction yield was calculated using the BCA 
Protein Assay (Pierce), as previously described in Ref [74]. 
 
2.2. Preparation of RGD-alginate hydrogel matrices 
 
In situ forming alginate hydrogel matrices were prepared by internal gelation as 
described previously [73, 74, 77]. Hydrogel precursor solution was prepared at 1 wt.% 
sodium alginate in 0.9 wt.% NaCl, with 200 μM RGD, a density comparable to that 
present in commonly used ECM-derived biological matrices [106]. The solution was 
sterile-filtered (0.22 μm) and mixed with an aqueous suspension of sterile CaCO3 
(Fluka) at a CaCO3/COOH molar ratio of 1.6 [107]. Then, a fresh sterile solution of 
glucone delta-lactone (GDL, Sigma) was added to trigger gelation. The CaCO3/GDL 
molar ratio was set at 0.125, and the gelation time was 30 to 45 min.  
 
2.3. In situ stiffening and softening of RGD-alginate hydrogel matrices 
 
For stiffening, acellular or cell-laden (prepared as described in the next section) 
alginate hydrogels were transferred to 8 µm transwells (eppendorf) and placed in a 
solution of CaCl2 (0.1 M or 50 mM) or SrCl2 (50 mM or 25 mM) for different periods of 
time. For softening, hydrogels in transwells were placed in sodium-citrate (50 mM, 25 
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mM or 12.5 mM) for different periods of time. Two cycles were carried out where the 
same hydrogels were stiffened (with CaCl2 or SrCl2) and then softened (with sodium-
citrate) and vice-versa. After immersion on these solutions, the transwell was moved to 
a well with culture medium for 30 minutes to reach equilibrium. 
Rheological measurements were carried out using a Kinexus Pro rheometer (Malvern). 
Hydrogel discs without cells were analyzed at day 0 (after swelling to equilibrium in 
culture media for 1 h) under standard culture conditions. For cellular hydrogels, discs 
were only analysed after one day of stiffening. To guarantee the dimensional 
homogeneity of the samples, 4 mm cylinders were punched from the original ones 
immediately before analysis. All samples were assayed using a plate-and-plate 
geometry (4 mm diameter, sandblasted surfaces) and were compressed to 30% of their 
original thickness to avoid slippage. A solvent trap was used to minimize sample 
drying. All measurements were performed at 37 ºC (Peltier system). Stress sweeps 
(0.1 Hz) were first performed to determine the LVR. Frequency sweeps (0.01–2 Hz) 
were then performed within the LVR. The values of the shear storage modulus (G’) 
were obtained at a frequency of 0.1 Hz. Samples were analyzed at least in triplicate.  
To optimize acellular alginate hydrogels rheological properties, unmodified alginate 
was used and crosslinked with either CaCO3 or SrCO3. For the first case, hydrogels 
were prepared as described above and for the SrCO3-based hydrogels, the 
SrCO3/GDL ratio was also set at 0.125, but the concentration of SrCO3 used was half 
of the CaCO3.  
 
2.4. 3D culture of EpH4 cells in RGD-alginate matrices 
 
For cell entrapment, EpH4 cells [108] (5 x 106 cells/mL) were combined with RGD-
alginate solution and crosslinking agents and the mixture was pipetted (20 μL) onto 
Teflon plates separated by 750 µm-height spacers. To quantify spheroid formation 
during epithelial morphogenesis discs with 8 μL and 250 µm height were made. After 
gelation, 3D matrices were transferred to pHEMA-treated 24-well culture plates. 
Thereafter, fresh medium was added and renewed after 1 h. 3D culture of EpH4 
(classified as E for epithelial) were maintained in DMEM/F-12 with glutamax (Gibco) 
supplemented with 5% v/v FBS (Biowest), 1% v/v penicilin/streptomycin (Gibco) and 5 
μg/mL insulin solution human (Sigma). 
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2.5. Viability, proliferation and metabolic activity in 3D  
 
Cell viability was evaluated using the Live/Dead assay. Cell-laden matrices were 
washed three times with DMEM/F-12 without phenol red (Gibco), then incubated (45 
min, 37 ºC in the dark) with calcein AM (1 μM, live cells) and ethidium homodimer-1 
(EthD-1, 2.5 μM, dead cells) and washed again. Samples were imaged by confocal 
laser scanning microscopy (CLSM, Leica SP2 AOBS SE).  
Cell proliferation was assessed by Ki-67 immunostaining. EpH4-laden hydrogels were 
fixed with 4 wt.% paraformaldehyde (PFA, Sigma) in TBS-Ca (TBS with 7.5 mM CaCl2) 
for 20 min, permeabilized for 5 min with 0.2% v/v Triton X-100/TBS-Ca, and then 
incubated for 1 h in 1 wt.% bovine serum albumin (BSA) in TBS-Ca to block unspecific 
binding. Finally, samples were incubated with goat anti-rabbit secondary antibody 
Alexa Fluor 488 (Molecular Probes, Invitrogen, 1:1000, 1 h at RT) and nuclei were 
counterstained with DAPI. 
Cell metabolic activity was assessed using the resazurin assay. Cell-laden matrices 
were incubated with 20%v/v of the stock resazurin solution (0.1 mg/mL, Sigma) in 
medium for 2 h at 37ºC. The supernatant was then transferred to a 96-well plate black 
with clear bottom (Greiner) and fluorescence measurements were carried out using a 
microplate reader (Biotek Synergy MX) with Ex/Em at 530/590 nm. For each condition 
n=3 replicates were analyzed from 3 different biological replicas. 
 
2.6. Analysis and quantification of spheroids formation 
 
For analysis of spheroids formation, EpH4 cells were pre-labeled with CellTracker 
Green CMFDA (Molecular Probes) at 15 μM for 30 min, and then entrapped within 
alginate matrices as described. Whole-mounted samples with fluorescence-labeled 
cells within alginate matrices were imaged by CLSM at different time points (days 1, 7 
and 14). For quantifications of spheroids number and size during epithelial 
morphogenesis, EpH4-laden hydrogels were fixed, permeabilized and blocked as 
described above. F-actin filaments were stained with Alexa Fluor 488 phalloidin 
(Invitrogen, 1:40 in 1 wt.% BSA/TBS-Ca, 1 h at RT) and nuclei were counterstained 
with DAPI. Samples were analysed by CLSM. The scanned Z-series were projected 
onto a single plane and spheroid diameter and number was assessed with Fiji. Three 
independent gels were analyzed for each condition and 1316 spheroids images were 
analyzed overall.  
For the quantification of spheroids diameter in the case of matrix stiffening versus 
control samples, samples were also fixed, permeabilized and blocked; however, only 
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DAPI staining was performed. The results were visualized by CLSM and analysed in 
Fiji, as described above. In this case, only one hydrogel was considered per condition. 
 
2.7. Phenotypic analysis by immunofluorescence 
 
EpH4-laden matrices were fixed, permeabilized and blocked as described in previous 
section. Subsequently, samples were incubated with the following primary antibodies: 
rabbit anti-E-cadherin (Cell Signalling, 1:100, 2 hours at RT) and rabbit anti-Vimentin 
(GenScript, 1:100, overnight at 4ºC). Finally, samples were incubated with goat anti-
rabbit secondary antibody Alexa Fluor 594 (for E-cadherin) and 488 (for vimentin) 
(Molecular Probes, Invitrogen, 1:1000, 1 h at RT) and nuclei were counterstained with 
DAPI. 
 
2.8. mRNA expression by qRT-PCR 
 
RNA was extracted from EpH4-laden matrices using the Quick-RNA MiniPrep (Zymo 
Research), as recommended by the manufacturer. Subsequently, 1000 ng of total RNA 
were reversed transcribed to single stranded cDNA using Superscript First-strand 
synthesis and random hexamer primers (Invitrogen). Quantitative Real-Time PCR 
(qRT-PCR) was carried out using source RNA from one biological replica for the target 
genes CDH1, Ocln, CDH2, Zeb2, Mgat3, Id2 and for endogenous control GAPDH 
using as probe sets Mm00486909, Mm.PT.47.16166845, Mm00483212_m1, 
Mm.PT.47.13169136, Mm00447798_s1, Mm00711781_m1, 4352932 (Applied 
Biosystems and Integrated DNA Technologies) respectively. Samples were run in 
triplicates in the ABI Prism 7000 Sequence Detection System and data was analysed 
by the comparative 2(-ΔΔCT) method [109]. 
 
2.9. Matrix metalloproteinases (MMPs) secretion by gelatin zymography 
 
To detect secretion of MMPs (MMP2 and MMP9) by 3D cultured cells, cell culture 
supernatants were analyzed by gelatin-zymography from 1 biological replica. After 72 h 
after contact with the discs, conditioned media were collected, centrifuged to remove 
cell debris and loaded into gelatin-SDS polyacrylamide gels. Sample volumes were 
adjusted to yield equivalent total cell protein contents, which were quantified by the 
BCA Protein Assay (Pierce) in lysates of cells recovered from the hydrogels [74]. The 
gel was run in 1x Tris-Glycine SDS running buffer at 60 V (Mini Protean Tetra Cell 
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system, BioRad). After electrophoresis, gels were washed twice and subsequently 
incubated in MMP substrate buffer for 16 h at 37ºC. Afterwards, gels were washed and 
stained with Coomassie Brilliant Blue R-250 (Sigma). MMPs proteolytic activity was 
visualized as the presence of clear bands against a blue background of Coomassie 
Blue-stained gelatin substrate. Thereafter, the gel was washed with distilled water, 
scanned using the GS-800 Calibrated Densiometer (Bio-Rad) and MMPs activity was 
estimated by densitometric analysis (QuantityOne, Bio-rad). 
 
2.10. Statistical analyses 
 
Statistical analyses were performed using GraphPad Prism 6.0 software version 6.0f. 
The non-parametric Mann–Whitney test was used to compare two groups. To compare 
spheroid diameter and number, Unpaired t test was used. Results for all analysis with 
‘p’ value less than 0.05 were considered to indicate statistically significant differences. 
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3. Results and Discussion 
 
3.1. Stiffness of RGD-alginate matrices can be dynamically switched in situ 
3.1.1. Stiffening and softening of acellular hydrogels 
 
The storage modules (G’) of acellular RGD-alginate hydrogels crosslinked with CaCO3 
was around 700-800 Pa, in average. To induce stiffening (Figure 7), hydrogels were 
placed either in contact with 50 mM CaCl2, at previously optimized concentration (data 
not shown), for different periods of time (Figure 8A). Only 3 min of contact between the 
hydrogels and the solution were enough to significantly increase the storage modulus 
of the 3D matrices up to 4431±133.60 Pa, which was not further altered upon treatment 
for the longer time periods analyzed (5 and 15 min). This was probably because the 
diffusion of calcium ions into the network was very fast, and calcium-binding sites in 
alginate chains became rapidly saturated. A Student’s t-test was conducted and there 
were significant differences between the control and all the hydrogels submitted to 
CaCl2 solution (p<0.0001). Since 3 min were enough to observe a significant difference, 
attaining a level of stiffness comparable to that of tumor tissues [49] this time period 
was chosen for the subsequent studies. 
 
Figure 7 - Schematic representation of the process used for stiffening and/or softening acellular 
hydrogels. 
 
On the other hand, to induce softening (Figure 7), hydrogels were placed in 25 mM Na-
citrate for 3 minutes (also an optimized condition, data not shown), which decreased 
their storage modulus (324.4±126.30 Pa) to levels lower than those of control 
hydrogels (800 Pa, p<0.0001, Figure 8B). This behavior was expected, since Na-citrate 
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acts as a calcium chelator, sequestering the crosslinking calcium ions from the 
hydrogel network, thus diminishing its integrity and, consequently, the overall storage 
modulus.  
 
 
Figure 8 - Viscoelastic properties (G’-storage modulus, Pa) of Ca-alginate hydrogels 
submitted to stiffening and/or softening processes. (A) Hydrogels stiffening with 50 mM 
CaCl2 for 3, 5 and 15 min. Data is presented as mean ± stdev (n=3). Significant differences 
were found in stiffened hydrogels (for all time periods) as compared to control (*p<0.0001). B) 
Hydrogels softening with 25 mM Na-citrate (3 min). Results are presented as average ± 
standard deviation (n=8). Significant differences were found in softened hydrogels as compared 
to control (*p<0.0001). C) Hydrogels stiffening (50 mM CaCl2, 3 min) followed by softening 
(25mM Na-citrate, 3 min). Data is presented as mean ± stdev (n=3 or 2 in the case of the CaCl2) 
(*p=0.0004). D) Hydrogels submitted to the opposite cycle i.e. softening plus stiffening. Data is 
presented as mean ± stdev (n=3 or 2 in the case of Na-citrate) (* p=0.0041 and **p=0.0361). E) 
Hydrogels stiffening was also performed with 50 mM SrCl2 for 3 min (*p<0.0001, n=3). 
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A stiffening/softening cycle was then tested (Figure 7). As expected, treating hydrogels 
with 50 mM CaCl2 for 3 min increased their stiffness in ca. 4.2-fold as compared to 
control (p=0.0004, Figure 8C), as previously observed. These hydrogels were then 
transferred to a 50 mM CaCl2 for 3 min, and their stiffness decreased, returning to the 
original values of control hydrogels.  
The opposite cycle of stiffening/softening was also tested. After softening, which 
resulted in a decrease of the storage modulus of ca. 2-fold as compared with the 
control, hydrogel’s stiffness could be again increased by transferring hydrogels to 50 
mM CaCl2 for 3 min. In this case, the hydrogels’ storage modulus was slightly higher 
than those of control hydrogels (ca. 1.3 fold) but in the same order of magnitude 
(Figure 8D).  
Although CaCl2 has been used as stiffening agent in previous works [100], we decided 
to also test here the effect of strontium ions, as calcium ions are implicated in several 
cellular functions, and it can be argued that changing local calcium concentration might 
eventually interfere with key cell signaling or cell adhesion mechanisms, for example. 
And, in fact, by treating hydrogels with 50 mM SrCl2 (Figure 8E), we were able to obtain 
results similar to those obtained with calcium, with storage modulus increasing to 
4244±104.10 Pa, as compared to control hydrogels (800 Pa, p<0.0001). 
Also, in view of a future conversion of the entire system to Sr-crosslinked hydrogels, 
similar experiments were performed using SrCO3 instead of CaCO3 as internal 
crosslinking agent (Figure 9). The SrCO3 alginate hydrogels were initially much stiffer 
than control CaCO3 hydrogels (~2000 Pa as compared to ~800 Pa), which was 
expected, since alginate chains present higher affinity towards strontium [97]. When 
hydrogels’ stiffness was further increased with 50 mM SrCl2 for 3 minutes, the storage 
modulus reached 12510±176.80 Pa. Treatment of control hydrogels with a less 
concentrated 25 mM SrCl2 solution was also tested. After 3 min, the storage modulus 
reached 8279±493.8 Pa (Figure 9A). These differences were statistical significant 
when compared to control (p<0.0001 and p=0.0002, respectively). It was interesting to 
be able to obtain two different levels of stiffness with SrCl2, since using CaCl2 at 
different concentrations and time points always resulted in similar levels of G’, which 
were never higher than 5000 Pa. The stiffened hydrogels (25 mM SrCl2, 3 min) were 
then transferred to 50 mM Na-citrate for 5 min and it was possible to observe a 
significant decrease in the storage modulus (2830±232.50 Pa) to a similar value of the 
control hydrogels. It is important to highlight than, in this case, treating hydrogels with 
25 mM Na-citrate for 3 minutes, as in the previous assays, was insufficient to 
significantly decrease the stiffness of the hydrogels (data not shown). Therefore, we 
had to adjust the concentration of sodium citrate to 50 mM and the time of contact to 5 
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min. 
The reverse process (softening/stiffening) was also performed (Figure 9B). After 
softening the hydrogels with 50 mM Na-citrate for 5 min, the storage modulus 
decreased to 416.4±86.68 Pa (p=0.0017, as compared to control). Subsequent 
stiffening with 25 mM SrCl2 for 3 min increased the storage modulus to 5105±51.62 Pa 
(p<0.0001, as compared to control), as expected, reaching values higher than those of 
control hydrogels, but lower than those of hydrogels treated only with SrCl2 (~8000 Pa). 
 
 
Figure 9 - Viscoelastic properties (G’-storage modulus, Pa) of Sr-alginate hydrogels 
submitted to stiffening and/or softening processes. (A) Stiffening was performed with two 
different concentrations of SrCl2 (50 mM and 25 mM) and softening was performed with 50 mM 
Na-citrate for 5 min (*p<0.0001, **p=0.0002, ***p=0.0034). B) The opposite cycle, softening 
followed by stiffening, was also conducted and storage moduli were determined (* p=0.0017, 
**p<0.0001). Data is presented as mean ± stdev (n=3). 
 
3.1.2. Stiffening and softening of epithelial cell-laden hydrogels 
 
After establishing adequate conditions for the in situ stiffening/softening of acellular 
hydrogels, the knowledge was transferred to cell-laden hydrogels. In this case, only 
hydrogels crosslinked with CaCO3 were used, to maintain the characteristics of the 
previously developed EMT/MET 3D model [104]. The cells used were near-normal 
mouse mammary epithelial EpH4 cells, which were embedded in RGD-alginate 
hydrogels at a concentration of 5 million cells per mL of hydrogel. 
Control cell-laden hydrogels were softer than the corresponding acellular hydrogels 
(~360 Pa as compared to ~800 Pa). This can be explained by the fact that cells occupy 
a certain volume within the hydrogel network, disturbing the process of calcium-
mediated binding of adjacent alginate chains and also creating defects in the network, 
which decreases the overall strength, and thus the storage modulus, of the hydrogels. 
A similar effect has been previously observed in other studies from our group [77, 110]. 
These hydrogels were stiffened (Figure 10) with 50 mM CaCl2 for different periods of 
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time (3 and 10 min). Contrary to that observed for acellular hydrogels, exposure to 
CaCl2 for distinct time periods resulted in different changes of the elastic modulus 
(654±52.14 Pa for 3 min, p=0.0013; and 1184±143.40 Pa for 10 min, p=0.0386, as 
compared to control). As the hydrogels have cells inside, the diffusion of calcium to 
stiffen the network can be slower, which may explain this effect. Hydrogels stiffened in 
50 mM CaCl2 for 10 min, were subsequently softened with 25 mM Na-citrate (Figure 
11A). Yet, the 3 min used for softening acellular hydrogels were not adequate for cell-
laden hydrogels, which irreversibly lost their integrity, so, in this case, 2 min were used 
instead, resulting in a decrease of the storage modulus to 264.7±33.99 Pa (p=0.002, as 
compared to control).  
 
 
Figure 10 - Schematic representation of the process used for stiffening and/or softening EpH4-
laden hydrogels. 
 
 
In the case of cell-laden hydrogels, it was important to evaluate whether 
stiffening/softening treatments would detrimentally affect the function of entrapped 
cells. Evaluation of cells metabolic activity using the resazurin assay revealed that it 
remained high after treatment with 50 mM CaCl2 for 10 min (98% of the control) and 
treatment with 50 mM CaCl2 followed by Na-citrate, (90% of the control) (Figure 11B). 
Stiffening of cell-laden hydrogels with SrCl2 also resulted in an increase of the storage 
modulus, similarly to that observed for acellular hydrogels. In this case, it was possible 
to obtain hydrogels with 2775±471 Pa after 10 min (p<0.0001), which could then be 
softened down to 1788±59.07 Pa after exposure to 50 mM Na-citrate for 5 min 
(p<0.0009, Figure 11C). Cells were also able to maintain high metabolic activity (Figure 
11D) after treatment with SrCl2 (80% of the control) and, intriguingly, the metabolic 
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activity attained an even higher value after a stiffening/softening a cycle of SrCl2 
followed by Na-citrate (97% of the control). A possible explanation for this is that 
softened hydrogels, which present a more permeable polymeric network, may possibly 
facilitate the diffusion of resazurin/resofurin during the incubation period of the 
metabolic activity assay, resulting in a technical artifact. 
After establishing adequate conditions for stiffening cell-laden hydrogels, the next step 
was to optimize conditions for softening these hydrogels (Figure 10). In this case, 
hydrogels that were treated with 25 mM Na-citrate for 3 or even 2 min could not be 
handled. After 1 min of contact, the hydrogels could be recovered, but their storage 
moduli were almost identical to those of control hydrogels. So, new tests were 
performed using half of the initial concentration of Na-citrate, i.e. 12.5 mM, for 3 and 5 
min. Hydrogels could be handled after both time points, and their storage moduli was 
quite similar, ca. 300 Pa. Statistical differences as compared to control hydrogels were 
only observed for the 3 min treatment (p=0.0355), and so this condition was selected 
for further experiments. Subsequent stiffening with 50 mM CaCl2, resulted in only a 
small increase in the storage modulus (from ~300 Pa to 479.5±59.13 Pa), but upon 
treatment of softened hydrogels with 50mM SrCl2, their storage modulus increased to 
3013±632.80 Pa (p=0.0023, Figure 9E). This different behavior might be partially 
explained by the higher affinity of alginate chains to strontium vs. calcium ions, which 
might favor a faster and more efficient hydrogel strengthening. 
Exposure to Na-citrate decreased epithelial cells metabolic activity to approximately 
73% of control hydrogels (Figure 9F). This was not totally unexpected, since Na-citrate 
sequesters some of the crosslinking calcium ions, opening/relaxing the network and, 
consequently, some cells will probably be released into the culture medium during the 
process. Likewise, the same occurred when cells were submitted to softening/stiffening 
cycle both with strontium or calcium (67% and 65%, respectively). This assumption 
was further confirmed by normalizing cell metabolic activity results in relation to the 
total amount of protein present in cells recovered from the matrix, which yielded values 
closer to ones of control hydrogels (the average RFU/μg total protein was 35±0.86 for 
controls, 24.91±2.05 for softened hydrogels and 20.75±5.73 for softened/stiffened 
hydrogels, data not shown).  
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Figure 11 - Viscoelastic properties (G’-storage modulus, Pa) of Ca-alginate hydrogels 
with EpH4 cells entrapped submitted to stiffening and/or softening processes. (A) 
Stiffening was performed with 50 mM CaCl2 (3 and 10 minutes) followed by softening with 25 
mM Na-citrate for 2 min (*p=0.0013, **p=0.0386, *** p=0.002). C) Stiffening was also performed 
with 50 mM SrCl2 for 3 and 10 minutes and softening was consequently executed with 50 mM 
Na-citrate for 5 minutes (*p=0.0009, **p<0.0001). E) Softening was performed with 25 mM Na-
citrate for 1 minute and with 12.5 mM Na-citrate (3 and 5 minutes). The cycle softening-
stiffening was carried out with both 50 mM SrCl2 and CaCl2 for 10 minutes (*p=0.0355, 
**p=0.0023). Metabolic activity (RFUs) was measured for the extreme conditions used (B, D, F). 
Data is presented as mean ± stdev (n=3 for each condition). 
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3.2. 3D culture in soft RGD-alginate matrices preserves the epithelial phenotype 
of normal mammary EpH4 cells and promotes epithelial morphogenesis  
 
Soft alginate hydrogels functionalized with cell-adhesion RGD peptides were used in 
this study to simulate the 3D microenvironment of normal breast tissue. Normal murine 
mammary epithelial EpH4 cells, which typically assume a polygonal or cuboidal shape 
in 2D monolayer culture (Figure 12A), formed multicellular spheroids with high cell 
viability when entrapped in RGD-alginate hydrogels (Figure 12A and B). This is 
consistent to other studies described in the literature, which demonstrated the ability of 
epithelial cells to grow in 3D and form spherical clusters [48, 111, 112]. The presence 
of cell adhesion RGD ligands in the matrix, at a density (200 µM) similar to that of 
common ECM-derived biological matrices [106], was essential, leading to higher cell 
metabolic activity (Figure 12C) and formation of more and larger spheroids. The 
compliance (G’≈ 200 Pa) of the selected artificial 3D matrix was comparable to that of 
normal mammary tissue [49, 113, 114], and its viscoelastic properties remained 
unchanged along the culture period (Figure 12D), as demonstrated by rheometry 
analysis of cell-laden 3D matrices. 
 
Figure 12 - Schematic representation of the established 3D in vitro model. A) Normal 
mammary epithelial cells (EpH4), were immobilized within 1 wt.% alginate matrix 
biofunctionalized with 200 μM RGD. To study epithelial morphogenesis, cells were kept in 
standard culture medium during 14 days (E cells).  Bright field microscopy images of EpH4 cells 
in 2D (tissue culture polysytere) and 3D (RGD-alginate matrix) after 14 days of culture. B) 
Live/dead assay performed in 3D-cultured EpH4 cells at day 14 revealed the presence of 
cellular aggregates composed mostly by live cells (green, calcein staining) with few isolated 
dead cells (red, ethidium homodimer-1). C) Metabolic activity of EpH4 cultured in 3D alginate 
matrices with (+) and without (-) RGD peptides (200 μM) after 7 days in culture. D) Viscoelastic 
properties (storage modulus, G’) of 1 wt.% RGD-alginate with EpH4 cells during 14 days of 
culture. Data is presented as mean ± stdev (n=3).  
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Immunodetection of proliferative cells (Ki67 proliferation marker) showed that EpH4, 
which were initially distributed as single cells within the 3D matrices, were able to 
proliferate, generating spheroids. At day 1, Ki-67 staining depicted proliferation in 
individual cells, but at days 7 and 14 proliferative cells were essentially restricted to 
spheroids (Figure 13A). The analysis of mitochondrial metabolic activity (Figure 13B) 
showed a significant increase along the first week of culture, suggesting that cells were 
actively proliferating, while from day 7 to day 14 no significant differences were 
observed, suggesting growth arrest. As time progressed, spheroids size increased 
reaching an average diameter of 30 μm at day 14 (Figure 13C and D). 
 
 
Figure 13 - Behavior of normal mammary EpH4 epithelial cells within an artificial 3D RGD-
alginate matrix. A) Proliferating epithelial cells (Ki-67 positive cells, arrows) were detected 
within the matrix at all time points (scale bars: 20 μm). B) The metabolic activity profile showed 
a significantly increase after 1 week of culture. C) EpH4 cells (labeled with CellTrackerTM green) 
formed spheroids that increased in size and number along 14 days of culture (scale bar: 100 
μm). D) After 14 days of culture, spheroids reached an average diameter of 20 μm. Data is 
presented as mean ± stdev (n=3). Statistical significance, **p<0.01, ***p<0.001. 
 
After 10-14 days in culture, actin-staining of EpH4-laden hydrogels revealed the 
formation of uniform spheroids (Figure 14A). The larger spheroids showed central 
clearing and lumen formation, surrounded by an organized layer of single cells 
reminiscent of the breast acini (Figure 14C and D).These structures showed peripheral 
nuclear alignment and apical-basal polarity maintained by the precise arrangement of 
actin filaments [115], namely at interior luminal surface and at cell-cell junctions. Similar 
behaviours have also been described in the literature, for instance, for MCF10A 
epithelial cells entrapped within a 3D matrix (composed of an interpenetrating network 
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of alginate and reconstituted basement membrane), which also formed typical 
mammary acinar structures with growth arrest, lumen formation and apicobasal 
polarization [111]. These structures also stained positively for functional E-cadherin 
(Figure 14B), a prototypical epithelial marker, which was localized at the cell 
membrane, stabilizing cell-cell contacts within spheroids. 
By qRT-PCR, we assessed the mRNA expression of epithelial markers, CDH1 
(encoding E-cadherin) and Ocln (encoding Occludin); mesenchymal marker CDH2 
(encoding N-cadherin); and transcription factor Zeb2, a well-known EMT inducer 
(Figure 14E). None of the assessed markers were significantly altered across time, 
suggesting that 3D culture within RGD-alginate hydrogels preserves EpH4 cells 
epithelial phenotype and supports normal epithelial morphogenesis. This is also in 
accordance with the literature. For example, in one study with SCp2 cells, soft 
substrate with elastic modulus similar to that of normal mammary tissue were also 
found to be protective against EMT [112]. 
 
 
 
Figure 14 - Culture in RGD-alginate 3D matrix supports epithelial morphogenesis. CLSM 
images of 3D-cultured epithelial cells at day 14, showing: A) spheroids formation; with C and D) 
lumenization; and B and D) expression of the classical epithelial marker E-cadherin. Cell nuclei: 
blue, F-actin: green, E-cadherin: red. Scale bars (A, C, D and inset image in B): 20 μm, B): 50 
μm. E) qRT-PCR quantification of relative mRNA expression of CDH1 and Ocln (E markers), 
CDH2 (M marker) and Zeb2 (EMT inducer). Expression of the different markers was not 
significantly altered during the 14 days of culture. Data was normalized for E cells and 
presented as mean ± standard deviation (n=4 biological replicas). 
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3.3. Effect of in situ matrix stiffening on the behaviour of EpH4 cells cultured 
under 3D conditions in soft RGD-alginate matrices 
 
After demonstrating that soft RGD-alginate hydrogels provide an adequate 
environment for normal epithelial morphogenesis, and do not promote EMT per se, 
the effect of in situ matrix stiffening on 3D cultured EpH4 cells was evaluated. The 
stiffening process was further optimized in this set of experiments, by increasing 
the concentration of the SrCl2 solution from 50 mM to 100 mM (Figure 15A), and thus 
attain a level of stiffness closer to the one found in tumour microenvironments, i.e. 
around 4000 Pa [49].  
Two experimental settings were tested, where matrices were stiffened 1 day after 
cell entrapment (as tested in 3.1 section), or only at day 10, after spheroids 
formation/maturation, which occurs around day 10 (as previously observed in 
section 3.2 and in Figure 15B). As seen in Figure 15C, the higher level of stiffening 
did not detrimentally affect cellular metabolic activity which remained constant and 
comparable to the control along 1 week of culture. Therefore, subsequent 
experiments were made using 100mM SrCl2 as stiffening agent.  
 
Figure 15 - Cell-laden alginate hydrogels stiffened with different concentrations of SrCl2 
and cellular metabolic activity. A) Stiffening was performed with both 50mM and 100mM 
SrCl2 for 10 minutes (*p=0.0013, **p<0.0001). B) At day 10, large spheroids showed central 
clearing and lumen formation, surrounded by an organized layer of single cells reminiscent of 
the breast acini (scale bar 20 m) and express the classical epithelial marker E-cadherin. Cell-
laden hydrogels were stiffened at this time point, and maintained in culture under stiffened 
conditions for 7 days. C) Metabolic activity was measured in cell-laden matrices at day 10 
(immediately after stiffening) and at day 17 (after 7 days in culture); the data is expressed as 
fold increase relative to control matrices at day 10. Data is represented as mean ± stdev (n=3).  
 
 
In the first set of experiments, where cell-laden matrices were stiffened at day 1 cellular 
metabolic activity increased from day 1 to day 7, in control matrices, as observed in the 
previous section. However, in stiffened matrices, the metabolic activity increased in the 
first 3 days of culture, but at day 7, the value decreased, suggesting some growth 
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arrest (Figure 16A). Results from total protein quantification of the same samples were 
in agreement with those of metabolic activity assay (Figure 16B). DNA quantification 
showed a different result, as the values increased from day 1 to 7 in both conditions 
(Figure 16C). Yet, data from stiffened matrices at day 7 were not very consistent, 
having high standard deviations, and so these experiments must be repeated to yield 
conclusive results. 
Spheroids formation was observed at day 7 in both control and stiffened matrices 
(Figure 16D). Their diameter was measured and statistical significant differences were 
found between the two conditions (p<0.0001, Figure 16E). Spheroids in control 
matrices had an average diameter of 60 µm, while spheroids in stiffened matrices had 
an average diameter of approximately 30 µm. An explanation for the observed results 
is still unclear. On one hand, matrix stiffness in itself may be interfering with normal 
epithelial morphogenesis and/or inducing phenotypic alterations, as previously 
described in other 3D models [111]. On the other hand, the observed differences in 
terms of spheroids size are also likely to be related with the more restrictive network of 
the stiffened matrices, which may provide a physical barrier for clonal cell growth.  
 
Figure 16 - Cell-laden alginate hydrogels stiffened at the first day of culture. A) Metabolic 
activity (RFUs) from control (C) and stiffened (S) matrices at day 1 (D1), day 3 (D3) and day 7 
(D7) (*p=0.036, **p=0.001 and ***p=0.0005). B) Protein quantification was measured for the 
conditions depicted above (*p=0.0028). C) DNA quantification was also performed (*p=0.02 and 
**p=0.03). D) Spheroids were visualized with DAPI staining (scale bar 50 µm) and their 
diameters were measured at day 7 for both conditions (E) (*p<0.0001, n=60). Data is presented 
as mean ± stdev with triplicates for each condition, except in the case of C D1 and C D7 DNA 
quantification where only two replicates were used.  
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Phenotypic analysis was also performed to check the expression of with typical E and 
M markers, at protein level, namely E-cadherin and Vimentin, respectively (Figure 17A 
and B). At day 7, cell spheroids in control matrices, expressed high levels of E-
cadherin, which was localized at the cellular membrane, where it promotes cell-cell 
adhesion. However, in stiffened matrices E-cadherin staining was less pronounced, 
being absent in some spheroids and/or not always present at the cellular membrane 
with some apparent delocalization into the cytoplasm. Vimentin expression, on the 
other hand, was almost absent in control samples and slightly increased in stiffened 
matrices. The observed decrease of the tested E marker and concomitant increase in 
the M marker suggests that the increase in matrix stiffness has some effect in 3D 
cultured epithelial cells. 
 
Figure 17 – EMT related markers expression at protein and mRNA levels in control and 
stiffened 3D matrices. A) E-cadherin expression (red, E marker) in control vs stiffened 
matrices (scale bar 50 m). B) Vimentin (green, M marker) expression also in control vs 
stiffened matrices (scale bar 50 m). Nuclei are counterstained in blue (DAPI). C) mRNA 
expression of EMT-related markers by RT-PCR (CDH1, Ocln – E; CDH2 - M; Zeb2 – EMT 
inducer; Mgat3, Id2 – epithelial-associated markers) in stiffened matrices normalized to control 
matrices for each marker.    
 
To better clarify this, we also analysed the mRNA expression of some EMT-related 
markers by qRT-PCR, namely of CDH1 (encoding E-cadherin, E marker), Ocln 
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(encoding occluding, E marker), CDH2 (encoding N-cadherin, M marker), Zeb2 (EMT 
inductor), Mgat3 (associated with loss of E-cadherin function [45, 101]) and Id2 
(inhibitor of differentiation 2, considered as a key negative regulator of EMT). When 
comparing stiffened cell-laden matrices with control ones after 7 days of culture (Figure 
17C), it can be concluded that mRNA expression of CDH1 was increased in stiffened 
samples, even if E-cadherin function seems to be impaired as suggested by its 
expression pattern at protein level. Interestingly, a similar result has been previously 
observed in our TGFβ1-induced EMT/MET 3D model [104]. Yet, expression of Ocln, 
another important E marker was downregulated. Expression of CDH2 encoding the 
mesenchymal proteins N-cadherin, and of transcriptional factor Zeb2 were both slightly 
increased in stiffened vs. control matrices. We also observed a significantly down-
regulation in mRNA expression of Mgat3, as in our previous 3D model [104]. Mgat3 
encodes for N-acetylglucosaminyltransferase III (GnT-III), which modulates the 
glycation state of E-cadherin in epithelial adherens-junctions, leading to E-cadherin 
internalization and disruption of cell-cell contacts [45, 116]. It has been previously 
shown that Mgat3 expression was dramatically decreased during EMT in 2D, and later 
recovered when cells partially returned to an epithelial-like phenotype, and therefore 
Mgat3 glycogene (and GnT-III mediated glycosylation, specifically on E-cadherin) has 
been identified as novel and major component of the EMT mechanism signature. On 
the other hand, Id2 is a member of the helix-loop-helix (HLH) protein family that has 
been described as an EMT antagonist, maintaining epithelial differentiation. Strong 
suppression of Id2 expression has been observed during EMT in different epithelial 
models, and forcing Id2 expression in mesenchymal cells has been shown partially 
rescue an epithelial phenotype [117-120]. Yet, although a significant decrease in Id2 
expression has been observed in our previous TGFβ1-induced EMT/MET 3D model, 
no differences between control and stiffened matrices were detected here. So, 
although some phenotypic alterations were detected in E cells cultured in stiffened vs. 
controlled matrices, eventually suggesting partial transition to a more M-like state, it 
must be highlighted that these experiments are still very preliminary, referring to only 
one biological replicate. Therefore, no solid conclusions on EMT occurrence can be 
taken at this stage. 
 
The second set of experiments, where the stiffening was only performed after the 
formation of lumenized spheroids (day 10) revealed different results. Cellular metabolic 
activity levels remained nearly constant from day 10 to 17 and were similar for both 
conditions (Figure 18A). Also, no statistical differences were found in terms of total 
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protein or dsDNA quantification (Figure 18 and C), and differences in spheroids size 
was also much less pronounced between the two conditions (Figure 18D). 
 
Figure 18 - Cell-laden alginate hydrogels stiffened after 10 days of culture, to allow 
spheroid formation. A) Metabolic activity (RFUs) from control (C) and stiffened (S) matrices at 
day 10 (D10), day 13 (D13) and day 17 (D17). B) Protein quantification and DNA quantification 
(C) were measured for the conditions depicted above. D) Spheroids were visualized with DAPI 
staining (scale 50 m) and their diameters were measured at day 17 for both conditions (E) 
(*p<0.0001, n=60). Data is presented as mean ± stdev with triplicates for each condition, except 
in the case of S D17 and C D10 protein and DNA quantification, respectively, where only two 
replicates were considered.  
 
Likewise, in terms of phenotypic markers, although some small differences were 
detected between control and stiffened matrices at protein expression level, with 
apparent lower expression of E-cadherin and higher expression of Vimentin (Figure 
19A and B), no consistent differences were detected at mRNA expression levels 
(Figure 19C). 
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Figure 19 - Epithelial and mesenchymal markers expression in cell-laden matrices 
stiffened after 10 days of culture. A) E-cadherin expression (red, E marker) in control vs 
stiffened matrices (scale bar 50 m). B) Vimentin (green, M marker) expression also in control 
vs stiffened matrices (scale bar 50 m). DAPI is counterstained in blue (nucleus). C) E and M 
markers gene expression by RT-PCR (CDH1, Ocln – E; CDH2 - M; Zeb2 – EMT inducer; 
Mgat3, Id2 – epithelial-associated markers) in stiffened matrices normalized with control values 
for each marker.    
 
Cells undergoing EMT are known to acquire a migratory phenotype and increased 
invasion capacity, features also seen in tumor cells that invade and metastasize. 
Migration and invasion are often correlated with increased levels of matrix 
metalloproteinases (MMP) activity [121], namely MMP2 and MMP9 which have a key 
role in ECM degradation [122]. In this study, we quantified the activity of MMP2 and 
MMP9 (Figure 20) in conditioned media from 3D cultures. Our results show that while 
in the first set of experiments (matrices stiffened at day 1) the activity of both MMP2 
and MMP9 slightly increased from day 1 to day 7, no differences were found between 
control and stiffened samples. In the second set of experiments (matrices stiffened at 
day 10), no differences were observed between the different time points and the 
different conditions. Yet, unfortunately, it was not possible to repeat this experiment, 
which refers to one biological replicate only, and so these results are not conclusive.  
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Figure 20 - MMPs secretion by cells entrapped in control or stiffened matrices. MMP2 (A) 
and MMP9 (B) secretion of control and stiffened cell-laden matrices at day 1 measured after 7 
days in culture. The values were normalized with the MMPs secretion in control matrices at day 
1 and are represented as fold increase. C) Zimogram for control matrices (day 1 and 7) and 
stiffened ones (day 7). MMP9 band appears at around 92 kDa and MMP2 at 72 kDa. MMP2 (D) 
and MMP9 (E) secretion were also analysed in matrices stiffened only after the formation of 
spheroids. F) Zimogram for control cell-laden matrices (day 10 and 17) and stiffened matrices 
(day 17). 
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4. Concluding Remarks and Future Perspectives   
 
Recently, there has been a paradigm shift on cancer studies, as the role of ECM 
mechanical properties has started to be analysed in greater detail, appearing to play a 
major role on cancer progression and malignancy. In several studies where different 
cancer types have been analysed, from breast cancer, to prostate cancer and even 
brain cancers, the increased matrix rigidity surrounding the tumour seems to lead to 
enhanced tumour progression and poor prognosis [49, 111, 114, 123-130]. Yet, how 
the mechanical stimuli induce this malign progression still needs to be better clarified. 
In the literature, the most prevalent studies on the role of matrix stiffness on tumour 
progression are with epithelial cancers, with a high emphasis on breast tumours. In 
particular, EMT/MET transitions that occur in this type of cancer are currently also 
under intense investigation and have been correlated with ECM rigidity in a way that 
higher rigidity seems to be associated with increased malignancy. 
Here, we tried to develop a new 3D in vitro model to help in dissecting the role of ECM-
driven mechanical stimuli on EMT, taking advantage of a previous TGF1-induced 
EMT/MET 3D model previously described in the group [104]. This model was already 
quite useful, as compared to traditional 2D models, being more physiologically relevant 
and providing a closer view to the in vivo environment. The model is based on the use 
of alginate, a biocompatible and biodegradable hydrogel that mimics the ECM 
structure, modified with RGD peptides to promote cell-matrix adhesion. Here, the aim 
was to further improve these artificial microenvironments, to allow the dynamic tuning 
of their mechanical properties “on demand”, and precisely modulate cell-matrix 
interactions in a systematic way. 
Using the original 3D model, we designed a protocol to alter the mechanical strength in 
situ, by stiffening the matrix with CaCl2 or SrCl2 and softening with sodium citrate. 
Interestingly, we were also able to set-up mechanical cycles where the same hydrogel 
could be stiffened and then softened, and vice versa. When epithelial EpH4 cells were 
entrapped in the hydrogels, the same processes could be promoted, without 
detrimentally affect cell behaviour. We then validated the model as an adequate 
microenvironment for the culture of mammary epithelial cells, showing that epithelial 
morphogenesis could be recapitulated with 3D cultured EpH4, which preserved their 
epithelial phenotype when the hydrogel stiffness was close to the one of normal breast 
tissue [49]. Finally, using the optimized in situ stiffening technique, we wanted to 
investigate the effect of matrix mechanical properties on epithelial cell behaviour, 
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namely to see if increasing matrix stiffness to values close to the ones of mammary 
tumour tissue [49] could, per se, induce EMT without further exogenous stimuli. Matrix 
stiffening was promoted at day 1 or 10 of culture, before and after epithelial spheroids 
formation, respectively. In the first set of experiments (stiffening at day 1), we were 
actually able to detect some phenotypic alterations in E cells cultured in stiffened vs. 
controlled matrices, eventually suggesting partial transition to a more M-like state. Yet, 
there was not enough time to repeat these experiments, and so no solid conclusions on 
EMT occurrence can be taken at this stage. Future studies should be focused on the 
repetition of these experiments, using an increased number of replicates, especially for 
the case of qRT-PCR and MMPs analysis.  
Many other relevant aspects could be further investigated in the future using the 
proposed 3D model. For example, while the studies described herein were focused on 
the effect of matrix stiffness alone, it will be interesting, based on results from the 
literature, to study the potentially synergistic effects of concomitantly using other well-
described EMT inducers such as TGF1 or even MMP3 [48]. 
Moreover, we could try to first induce the transition of E cells along EMT/MET with 
TGF1 as described in our previous model [104], to generate cells in the other states 
(i.e. mesenchymal-like cells and reverted epithelial cells), and evaluate the effect of 
matrix stiffness on those stages. Studying the effect of matrix stiffening/softening cycles 
along EMT/MET would also be quite relevant. 
Our 3D model would also benefit from a parallel study using other cell lines, namely 
cells with cancerous background to compare with our results on near-normal epithelial 
cells, and the use of human derived cell lines should also be an asset. As already 
described, in future studies the entire system could also be converted into a “calcium-
free” system, using exclusively strontium as crosslinking agent, as calcium ions are 
implicated in several key cellular functions. 
 
 
 
 
 
  
41 
 
5. References 
 
[1] Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. The J 
Clinical Invest. 2009;119:1420-8. 
[2] Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal 
transition and breast cancer. Breast Cancer Res. 2009;11:213-. 
[3] Yang J, Weinberg RA. Epithelial-Mesenchymal Transition: At the Crossroads of 
Development and Tumor Metastasis. Dev Cell. 2008;14:818-29. 
[4] Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev 
Cancer. 2002;2:442-54. 
[5] Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clinical 
Invest. 2009;119:1420-8. 
[6] Huang X, Hang R, Wang X, Lin N, Zhang X, Tang B. Matrix stiffness in three-
dimensional systems effects on the behavior of C3A cells. Artif Organs. 2013;37:166-
74. 
[7] Brabletz T. EMT and MET in Metastasis: Where Are the Cancer Stem Cells? 
Cancer Cell. 2012;22:699-701. 
[8] Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of 
epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. 
Cancer Cell. 2012;22:725-36. 
[9] Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, Jimenez-
Heffernan JA, et al. Epithelial to mesenchymal transition and peritoneal membrane 
failure in peritoneal dialysis patients: pathologic significance and potential therapeutic 
interventions. Journal of the American Society of Nephrology : JASN. 2007;18:2004-13. 
[10] Palena C, Fernando RI, Hamilton DH. An immunotherapeutic intervention against 
tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition. 
Oncoimmunology. 2014;3:e27220. 
[11] Chui MH. Insights into cancer metastasis from a clinicopathologic perspective: 
Epithelial-Mesenchymal Transition is not a necessary step. Int J Cancer. 
2013;132:1487-95. 
[12] Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, et al. TGF-beta: 
duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst. 
2014;106:djt369. 
[13] Wendt MK, Allington TM, Schiemann WP. Mechanisms of the epithelial-
mesenchymal transition by TGF-beta. Future oncology (London, England). 
2009;5:1145-68. 
42 
 
[14] Zhang H, Liu L, Wang Y, Zhao G, Xie R, Liu C, et al. KLF8 involves in TGF-beta-
induced EMT and promotes invasion and migration in gastric cancer cells. J Cancer 
Res Clin Oncol. 2013;139:1033-42. 
[15] Vittal R, Fan L, Greenspan DS, Mickler EA, Gopalakrishnan B, Gu H, et al. IL-17 
induces type V collagen overexpression and EMT via TGF-beta-dependent pathways 
in obliterative bronchiolitis. Am J Physiol Lung Cell Mol Physiol. 2013;304:L401-14. 
[16] Massague J. TGFbeta in Cancer. Cell. 2008;134:215-30. 
[17] Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the 
nucleus. Cell. 2003;113:685-700. 
[18] Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, et al. Snail, 
Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness 
in metastatic ovarian and breast carcinoma. Cancer. 2005;103:1631-43. 
[19] Thiery JP, Huang R. Linking epithelial-mesenchymal transition to the well-known 
polarity protein Par6. Dev Cell. 2005;8:456-8. 
[20] Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, et al. Pten loss 
and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from 
prostate cancer stem/progenitor cells. Cancer research. 2012;72:1878-89. 
[21] Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and 
tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in 
tumor cell adhesion. Sem Cancer Biol. 2010;20:161-8. 
[22] Ridley AJ. Life at the leading edge. Cell. 2011;145:1012-22. 
[23] Schoumacher M, Goldman RD, Louvard D, Vignjevic DM. Actin, microtubules, and 
vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 
2010;189:541-56. 
[24] Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor 
progression. Ann N Y Acad Sci. 2004;1014:155-63. 
[25] Mongroo PS, Rustgi AK. The role of the miR-200 family in epithelial-mesenchymal 
transition. Cancer Biol Ther. 2010;10:219-22. 
[26] Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal 
transition. Nature Rev Mol Cell Biol. 2014;15:178-96. 
[27] Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling 
mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 
2008;105:6392-7. 
[28] Kaidi A, Williams AC, Paraskeva C. Interaction between beta-catenin and HIF-1 
promotes cellular adaptation to hypoxia. Nat. Cell Biol. 2007;9:210-7. 
43 
 
[29] Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T, et al. Hypoxia attenuates 
the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am 
J Pathol. 2003;163:1437-47. 
[30] Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/LEF-1 signaling 
pathway in induction of EMT. Cell Biol. Int. 2002;26:463-76. 
[31] Kobayashi W, Ozawa M. The transcription factor LEF-1 induces an epithelial-
mesenchymal transition in MDCK cells independent of beta-catenin. Biochem. Biophys. 
Res. 2013;442:133-8. 
[32] Medici D, Nawshad A. Type I collagen promotes epithelial-mesenchymal transition 
through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biol. 2010;29:161-5. 
[33] Maier HJ, Schmidt-Strassburger U, Huber MA, Wiedemann EM, Beug H, Wirth T. 
NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of 
pancreatic carcinoma cells. Cancer Lett. 2010;295:214-28. 
[34] Vincent-Salomon A, Thiery JP. Host microenvironment in breast cancer 
development: epithelial-mesenchymal transition in breast cancer development. Breast 
Cancer Res. 2003;5:101-6. 
[35] Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin 
in the transition from adenoma to carcinoma. Nature. 1998;392:190-3. 
[36] Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is 
accelerated through immunosuppression during Snail-induced EMT of cancer cells. 
Cancer cell. 2009;15:195-206. 
[37] Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin 
(CDH1) gene. Human mutation. 1998;12:226-37. 
[38] Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, 
et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular 
breast cancers. The EMBO journal. 1995;14:6107-15. 
[39] Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, 
et al. E-cadherin transcriptional downregulation by promoter methylation but not 
mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br 
J Cancer. 2006;94:661-71. 
[40] Ling ZQ, Li P, Ge MH, Zhao X, Hu FJ, Fang XH, et al. Hypermethylation-
modulated down-regulation of CDH1 expression contributes to the progression of 
esophageal cancer. Int J Mol Med. 2011;27:625-35. 
[41] Zhao C, Bu X. Promoter methylation of tumor-related genes in gastric 
carcinogenesis. Histol Histopathol. 2012;27:1271-82. 
44 
 
[42] Moghbeli M, Moaven O, Memar B, Raziei HR, Aarabi A, Dadkhah E, et al. Role of 
hMLH1 and E-cadherin promoter methylation in gastric cancer progression. J 
Gastrointest Cancer. 2014;45:40-7. 
[43] Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour 
progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 
2007;7:415-28. 
[44] Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine 
phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 2005;17:459-
65. 
[45] Pinho SS, Oliveira P, Cabral J, Carvalho S, Huntsman D, Gartner F, et al. Loss 
and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a 
mechanism involved in epithelial-mesenchymal-epithelial transitions. PloS one. 
2012;7:e33191. 
[46] Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression 
of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J 
Cell Biol. 2000;148:779-90. 
[47] Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that 
interface with the entire organism. Dev Cell. 2010;18:884-901. 
[48] Leight JL, Wozniak MA, Chen S, Lynch ML, Chen CS. Matrix rigidity regulates a 
switch between TGF-beta1-induced apoptosis and epithelial-mesenchymal transition. 
Mol Biol Cell. 2012;23:781-91. 
[49] Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. 
Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241-54. 
[50] Markowski MC, Brown AC, Barker TH. Directing epithelial to mesenchymal 
transition through engineered microenvironments displaying orthogonal adhesive and 
mechanical cues. J Biomed Mater Res-A. 2012;100:2119-27. 
[51] Gill BJ, Gibbons DL, Roudsari LC, Saik JE, Rizvi ZH, Roybal JD, et al. A synthetic 
matrix with independently tunable biochemistry and mechanical properties to study 
epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res. 
2012;72:6013-23. 
[52] Wei SC, Fattet L, Tsai JH, Guo Y, Pai VH, Majeski HE, et al. Matrix stiffness drives 
epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 
mechanotransduction pathway. Nat Cell Biol. 2015;17:678-88. 
[53] Santos E, Hernandez RM, Pedraz JL, Orive G. Novel advances in the design of 
three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D. Trends 
Biotechnol. 2012;30:331-41. 
45 
 
[54] Maschler S, Grunert S, Danielopol A, Beug H, Wirl G. Enhanced tenascin-C 
expression and matrix deposition during Ras/TGF-beta-induced progression of 
mammary tumor cells. Oncogene. 2004;23:3622-33. 
[55] Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC. 
Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of 
epithelial ovarian cancer cells. Biomaterials. 2010;31:8494-506. 
[56] Huang YJ, Hsu SH. Acquisition of epithelial-mesenchymal transition and cancer 
stem-like phenotypes within chitosan-hyaluronan membrane-derived 3D tumor 
spheroids. Biomaterials. 2014;35:10070-9. 
[57] Shibata S, Marushima H, Asakura T, Matsuura T, Eda H, Aoki K, et al. Three-
dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-
mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway. Int J Oncol. 
2009;34:1433-48. 
[58] Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap 
between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8:839-45. 
[59] Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of 
normal and malignant breast epithelial cells. Nat Methods. 2007;4:359-65. 
[60] QGel. The Innovation of QGel. 2015. 
[61] Annabi N, Tamayol A, Uquillas JA, Akbari M, Bertassoni LE, Cha C, et al. 25th 
anniversary article: Rational design and applications of hydrogels in regenerative 
medicine. Adv Mater (Deerfield Beach, Fla). 2014;26:85-123. 
[62] Vats K, Benoit DS. Dynamic manipulation of hydrogels to control cell behavior: a 
review. Tissue Eng Part B Rev. 2013;19:455-69. 
[63] Gill BJ, West JL. Modeling the tumor extracellular matrix: Tissue engineering tools 
repurposed towards new frontiers in cancer biology. J Biomech. 2014;47:1969-78. 
[64] Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, et al. 
Engineering tumors with 3D scaffolds. Nat Methods. 2007;4:855-60. 
[65] Marx V. Tracking metastasis and tricking cancer. Nature. 2013;494:133-6. 
[66] Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv 
Rev. 2012;64:194-205. 
[67] Haug A, Larsen B, Smidsrod O. A study of the constitution of alginic acid by partial 
acid hydrolysis. Acta Chem Scand. 1966;20:183-90. 
[68] Andersen T A-EP, Dornish M. 3D Cell Culture in Alginate Hydrogels. Microarrays. 
2015;4:133-61. 
[69] Bidarra SJ, Barrias CC, Granja PL. Injectable alginate hydrogels for cell delivery in 
tissue engineering. Acta Biomater. 2014;10:1646-62. 
46 
 
[70] Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol 
Biosci. 2006;6:623-33. 
[71] Drury JL, Dennis RG, Mooney DJ. The tensile properties of alginate hydrogels. 
Biomaterials. 2004;25:3187-99. 
[72] Bidarra SJ, Barrias CC, Barbosa MA, Soares R, Granja PL. Immobilization of 
human mesenchymal stem cells within RGD-grafted alginate microspheres and 
assessment of their angiogenic potential. Biomacromol. 2010;11:1956-64. 
[73] Bidarra SJ, Barrias CC, Fonseca KB, Barbosa MA, Soares RA, Granja PL. 
Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells 
delivery. Biomaterials. 2011;32:7897-904. 
[74] Fonseca KB, Bidarra SJ, Oliveira MJ, Granja PL, Barrias CC. Molecularly designed 
alginate hydrogels susceptible to local proteolysis as three-dimensional cellular 
microenvironments. Acta Biomater. 2011;7:1674-82. 
[75] Fonseca KB, Gomes DB, Lee K, Santos SG, Sousa A, Silva EA, et al. Injectable 
MMP-sensitive alginate hydrogels as hMSC delivery systems. Biomacromol. 
2014;15:380-90. 
[76] Maia FR, Barbosa M, Gomes DB, Vale N, Gomes P, Granja PL, et al. Hydrogel 
depots for local co-delivery of osteoinductive peptides and mesenchymal stem cells. J 
Control Release 2014;189:158-68. 
[77] Maia FR, Fonseca KB, Rodrigues G, Granja PL, Barrias CC. Matrix-driven 
formation of mesenchymal stem cell-extracellular matrix microtissues on soft alginate 
hydrogels. Acta Biomater. 2014;10:3197-208. 
[78] Maia FR, Lourenco AH, Granja PL, Goncalves RM, Barrias CC. Effect of cell 
density on mesenchymal stem cells aggregation in RGD-alginate 3D matrices under 
osteoinductive conditions. Macromol Biosci. 2014;14:759-71. 
[79] Kaklamani G, Cheneler D, Grover LM, Adams MJ, Bowen J. Mechanical properties 
of alginate hydrogels manufactured using external gelation. J Mech Behav Biomed 
Mater. 2014;36:135-42. 
[80] Haug A. Affinity of some divalent metals to different types of alginates. 
Munksgaard int publ ltd 35 norre sogade, po box 2148, dk-1016 Copenhagen, 
Denmark; 1961. p. 1794-&. 
[81] Haug A, Smidsrod O. Selectivity of some anionic polymers for divalent metal ions. 
Acta chem scand. 1970;24:843-54. 
[82] Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue 
engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials. 
2001;22:511-21. 
47 
 
[83] Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Adv Polym 
Sci 2012;37:106-26. 
[84] Banerjee A, Arha M, Choudhary S, Ashton RS, Bhatia SR, Schaffer DV, et al. The 
influence of hydrogel modulus on the proliferation and differentiation of encapsulated 
neural stem cells. Biomaterials. 2009;30:4695-9. 
[85] Chu C, Schmidt JJ, Carnes K, Zhang Z, Kong HJ, Hofmann MC. Three-
dimensional synthetic niche components to control germ cell proliferation. Tissue 
Eng Part A. 2009;15:255-62. 
[86] Masuda K, Sah RL, Hejna MJ, Thonar EJ. A novel two-step method for the 
formation of tissue-engineered cartilage by mature bovine chondrocytes: the alginate-
recovered-chondrocyte (ARC) method. J Orthop Res. 2003;21:139-48. 
[87] Park H, Kang SW, Kim BS, Mooney DJ, Lee KY. Shear‐reversibly Crosslinked 
Alginate Hydrogels for Tissue Engineering. Macromol Biosci. 2009;9:895-901. 
[88] Penolazzi L, Tavanti E, Vecchiatini R, Lambertini E, Vesce F, Gambari R, et al. 
Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate microbeads. 
Tissue Eng Part C. 2009;16:141-55. 
[89] Sheng L, Leshchyns'ka I, Sytnyk V. Cell adhesion and intracellular calcium 
signaling in neurons. J Cell Commun Signal. 2013;11:94. 
[90] Tanaka M, Ichikawa-Tomikawa N, Shishito N, Nishiura K, Miura T, Hozumi A, et al. 
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human 
breast cancer and promotes cancer cell invasion. BMC cancer. 2015;15:53. 
[91] Duvivier-Kali VF, Omer A, Lopez-Avalos MD, O'Neil JJ, Weir GC. Survival of 
microencapsulated adult pig islets in mice in spite of an antibody response.  Am 
J Transplant 2004;4:1991-2000. 
[92] Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC. Complete protection of 
islets against allorejection and autoimmunity by a simple barium-alginate membrane. 
Diabetes. 2001;50:1698-705. 
[93] Omer A, Duvivier-Kali VF, Trivedi N, Wilmot K, Bonner-Weir S, Weir GC. Survival 
and maturation of microencapsulated porcine neonatal pancreatic cell clusters 
transplanted into immunocompetent diabetic mice. Diabetes. 2003;52:69-75. 
[94] Schneider S, Feilen PJ, Brunnenmeier F, Minnemann T, Zimmermann H, 
Zimmermann U, et al. Long-term graft function of adult rat and human islets 
encapsulated in novel alginate-based microcapsules after transplantation in 
immunocompetent diabetic mice. Diabetes. 2005;54:687-93. 
[95] Zekorn T, Horcher A, Siebers U, Schnettler R, Klöck G, Hering B, et al. Barium-
cross-linked alginate beads: a simple, one-step method for successful immunoisolated 
transplantation of islets of Langerhans. Acta Diabetol. 1992;29:99-106. 
48 
 
[96] Smidsrod O, Haug A. Properties of Poly (l, 4-hexuronates) in the Gel State. Acta 
Chem Scand. 1972;26:6. 
[97] Morch YA, Donati I, Strand BL, Skjak-Braek G. Effect of Ca2+, Ba2+, and Sr2+ on 
alginate microbeads. Biomacromol. 2006;7:1471-80. 
[98] Thu B, Bruheim P, Espevik T, Smidsrod O, Soon-Shiong P, Skjak-Braek G. 
Alginate polycation microcapsules. I. Interaction between alginate and polycation. 
Biomaterials. 1996;17:1031-40. 
[99] Martinsen A, Skjak-Braek G, Smidsrod O. Alginate as immobilization material: I. 
Correlation between chemical and physical properties of alginate gel beads. Biotechnol 
Bioeng. 1989;33:79-89. 
[100] Gillette BM, Jensen JA, Wang M, Tchao J, Sia SK. Dynamic hydrogels: switching 
of 3D microenvironments using two-component naturally derived extracellular matrices. 
Adv Mat (Deerfield Beach, Fla). 2010;22:686-91. 
[101] Oliveira P, Rocha S, Azevedo M, Vieira A, Ferreira D, Mendes N, Reis I, Vinagre 
J, Heravi-Moussavi A, Nunes JB, Lima J, Máximo V, Burleigh A, Roskelley C, Carneiro 
F, Seruca R, Paredes J, Huntsman D, Oliveira C. Through the looking glass: the 
reversion of EMT.  European Society of Human Genetics Conference 2015. 
[102] Schmidt JM, Panzilius E, Bartsch HS, Irmler M, Beckers J, Kari V, et al. Stem-
cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 
activation. Cell reports. 2015;10:131-9. 
[103] Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast 
tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. 
Science (New York, NY). 2013;339:580-4. 
[104] Bidarra SJ, Oliveira P, Saraiva D, Oliveira C, Barrias CC. A 3D in vitro model to 
explore the inter-conversion between epithelial and mesenchymal states during EMT 
and its reversion. Submitted. 2015. 
[105] Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic 
extracellular matrix materials. Biomaterials. 1999;20:45-53. 
[106] Huebsch N, Arany PR, Mao AS, Shvartsman D, Ali OA, Bencherif SA, et al. 
Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-
cell fate. Nat Materials. 2010;9:518-26. 
[107] Oliveira SM, Barrias CC, Almeida IF, Costa PC, Ferreira MR, Bahia MF, et al. 
Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle 
with in situ gel-forming ability. J Biomed Mater Res B Appl Biomater. 2008;87:49-58. 
[108] Montesano R, Soriano JV, Fialka I, Orci L. Isolation of EpH4 mammary epithelial 
cell subpopulations which differ in their morphogenetic properties. In Vitro Cell Dev Biol 
Anim 1998;34:468-77. 
49 
 
[109] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, 
Calif). 2001;25:402-8. 
[110] Fonseca KB, Maia FR, Cruz FA, Andrade D, Juliano MA, Granja PL, et al. 
Enzymatic, physicochemical and biological properties of MMP-sensitive alginate 
hydrogels. Soft Matter. 2013;9:3283-92. 
[111] Chaudhuri O, Koshy ST, Branco da Cunha C, Shin JW, Verbeke CS, Allison KH, 
et al. Extracellular matrix stiffness and composition jointly regulate the induction of 
malignant phenotypes in mammary epithelium. Nat Materials. 2014;13:970-8. 
[112] Lee K, Chen QK, Lui C, Cichon MA, Radisky DC, Nelson CM. Matrix compliance 
regulates Rac1b localization, NADPH oxidase assembly, and epithelial-mesenchymal 
transition. Mol Biol Cell. 2012;23:4097-108. 
[113] Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour 
progression. Nat Rev Cancer. 2009;9:108-22. 
[114] Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix 
crosslinking forces tumor progression by enhancing integrin signaling. Cell. 
2009;139:891-906. 
[115] Mi K, Xing Z. CD44(+)/CD24(-) breast cancer cells exhibit phenotypic reversion in 
three-dimensional self-assembling peptide RADA16 nanofiber scaffold. Int J 
Nanomedicine 2015;10:3043-53. 
[116] Xu Q, Isaji T, Lu Y, Gu W, Kondo M, Fukuda T, et al. Roles of N-
acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by 
transforming growth factor beta1 (TGF-beta1) in epithelial cell lines. J Biol Chem. 
2012;287:16563-74. 
[117] Chang C, Yang X, Pursell B, Mercurio AM. Id2 complexes with the SNAG domain 
of Snai1 inhibiting Snai1-mediated repression of integrin beta4. Mol Cell Biol. 
2013;33:3795-804. 
[118] Kondo M, Cubillo E, Tobiume K, Shirakihara T, Fukuda N, Suzuki H, et al. A role 
for Id in the regulation of TGF-beta-induced epithelial-mesenchymal 
transdifferentiation. Cell Death Differ. 2004;11:1092-101. 
[119] Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. Id2 and Id3 
define the potency of cell proliferation and differentiation responses to transforming 
growth factor beta and bone morphogenetic protein. Mol Cell Biol. 2004;24:4241-54. 
[120] Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. 
Oncogene. 2005;24:5764-74. 
50 
 
[121] Radisky ES, Radisky DC. Matrix Metalloproteinase-Induced Epithelial-
Mesenchymal Transition in Breast Cancer. J Mammary Gland Biol Neoplasia. 
2010;15:201-12. 
[122] Jacob A, Prekeris R. The regulation of MMP targeting to invadopodia during 
cancer metastasis. Front Cell Dev Biol. 2015;3:4. 
[123] Ahmad S, Cao R, Varghese T, Bidaut L, Nabi G. Transrectal quantitative shear 
wave elastography in the detection and characterisation of prostate cancer. Surg 
Endosc 2013;27:3280-7. 
[124] Boyd NF, Li Q, Melnichouk O, Huszti E, Martin LJ, Gunasekara A, et al. Evidence 
that breast tissue stiffness is associated with risk of breast cancer. PloS one. 
2014;9:e100937. 
[125] Fenner J, Stacer AC, Winterroth F, Johnson TD, Luker KE, Luker GD. 
Macroscopic stiffness of breast tumors predicts metastasis. Scientific reports. 
2014;4:5512. 
[126] Kaluzny J, Kopec T, Szczepanek-Parulska E, Stangierski A, Gurgul E, Ruchala 
M, et al. Shear wave elastography: a new noninvasive tool to assess the intensity of 
fibrosis of irradiated salivary glands in head and neck cancer patients. Biomed Res Int. 
2014;2014:157809. 
[127] Lam WA, Cao L, Umesh V, Keung AJ, Sen S, Kumar S. Extracellular matrix 
rigidity modulates neuroblastoma cell differentiation and N-myc expression. Mol 
Cancer. 2010;9:35. 
[128] Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, et al. The association of 
measured breast tissue characteristics with mammographic density and other risk 
factors for breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005;14:343-9. 
[129] Mouw JK, Yui Y, Damiano L, Bainer RO, Lakins JN, Acerbi I, et al. Tissue 
mechanics modulate microRNA-dependent PTEN expression to regulate malignant 
progression. Nat Med. 2014;20:360-7. 
[130] Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced 
mechanoregulation of breast cell phenotype, signaling and gene expression through a 
FAK-ERK linkage. Oncogene. 2009;28:4326-43. 
 
 
 
